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ABSTRACT
RATIONAL DESIGN OF SELF-ASSEMBLED NANOSTRUCTURES BASED ON
POLYMERS SYNTHESIZED VIA AQUEOUS REVERSIBLE ADDITIONFRAGMENTATION CHAIN TRANSFER POLYMERIZATION
by
Stacey Kirkland York
May 2010
Recent advances in reversible addition-fragmentation chain transfer (RAFT)
polymerization have allowed the rational, bottom-up design of biorelevant assemblies.
Utilizing foresight, polymers can be tailored to self-assemble into nano-, micro-, and
macroscopic structures. Given the size scale on which rationally-designed polymers can
be tailored, they hold significant promise in the biomedical field. For example, nanoscale
materials can be designed to carry small-molecule and gene therapeutics while
macroscopic structures can be tailored for cell growth scaffolds. The design process
begins by selecting monomers, chain transfer agents, and reaction conditions which will
yield the desired polymer architecture and composition. The work herein builds on these
concepts and may be divided into three sections.
In the first section, the synthesis of narrowly dispersed, temperature-responsive
BAB block copolymers capable of forming physical gels under physiological conditions
is described. A difunctional trithiocarbonate was utilized in the aqueous reversible
addition fragmentation chain transfer (RAFT) polymerization of the BAB block
copolymer, allowing a two-step synthetic approach to obtain a triblock copolymer with
symmetrical outer blocks. The outer B blocks of the triblock copolymers consist of
ii

poly(N-isopropylacrylamide) (P(NIPAM)) and the inner A block consists of either
poly(acrylamide) (P(AM)) or poly(N,N-dimethylacrylamide) (P(DMA)). The copolymers
form reversible physical gels above the phase transition temperature of P(NIPAM) at
concentrations as low as 7.5 wt% copolymer. Mechanical properties similar to that of
collagen, a naturally occurring polypeptide used as a three dimensional in vitro cell
growth scaffold, have been achieved. The mechanical properties of the gels as a function
of solvent, polymer concentration, and inner block length are discussed. Structural
information about the gels was obtained through pulsed field gradient NMR experiments,
confocal microscopy, and small angle x-ray microscopy.
In the second section, the reversible formation of ordered physical gels from
stimuli-responsive ABA [A=P(DMA), B= P(NIPAM))] triblock copolymers is
investigated utilizing dynamic light scattering, small angle x-ray scattering, and lowshear rheometry. As the temperature is increased above the phase transition temperature
of the P(NIPAM) segment, triblock copolymers under a critical molecular weight are
capable of packing into body-centered cubic arrays. Rheometric tests indicate that the
storage moduli of the gels at 50 ºC are inversely related to the molecular weight of the
polymer. In addition, cyclic heating of polymer solutions demonstrates the fast,
reversible nature of the physical gelation.
In the third section, the facile synthesis of polymer-stabilized Au nanoparticles
(AuNPs) capable of forming neutral, sterically stable complexes with small interfering
RNA (siRNA) is reported. The amine-containing cationic block of poly(N-2hydroxypropyl methacrylamide-block-N-[3-(dimethylamino)propyl] methacrylamide)
was utilized to promote the in situ reduction of Au+3 (NaAuCl4) in solution to Au0 (Au
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nanoparticles). Subsequently, this nanostructure was utilized to bind siRNA while the
nonimmunogenic, hydrophilic block provided steric stabilization. Significant protection
against nucleases was demonstrated by enzymatic tests while gene down-regulation
experiments indicated successful delivery of siRNA to cancerous cells.
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CHAPTER 1
INTRODUCTION
Rational Design of Biorelevant Assemblies
Recent advances in controlled radical polymerization (CRP) have allowed the
rational bottom-up design of biorelevant assemblies. Utilizing foresight, polymer block
length and side-chain functionality can be tailored to allow self-assembly under specific
conditions. As seen in Figure I-1, the judicious choice of monomer and polymer block
lengths can lead to a nanoassembly capable of inducing microscopic and macroscopic
responses. Given their high potential impact, the design of polymers for biomedical
applications, such as the theranostic nanocarrier (top) and temperature-responsive gel
(bottom) in Figure I-1, is of significant interest.
The design process begins by selecting monomers (Figures I-2, I-3), architecture,
and composition which will have the requisite properties for the desired application. Of
particular interest are polymers which assemble into nanostructures capable of producing
microscopic and macroscopic change. For example, the theranostic nanocarrier
illustrated in Figure I-1 (top) is assembled via electrostatic interactions between gene
therapeutic (yellow) and the polymeric stabilizing ligands (blue/red) coordinated to the
Au surface (pink). By simultaneously delivering the diagnostic gold nanoparticle and
gene therapeutic to cancer cells, real-time monitoring of treatment progression is realized.
The temperature-responsive gel (Figure I-1, bottom) forms as a result of the change in
hydrophilicity of the “light grey” block. In dilute solution micelles form via the
hydrophobic association of temperature-responsive blocks from multiple chains. Gelation
of the polymer solution occurs (macroscopic response) once a critical concentration of
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micelles is reached. By controlling polymer block length, important gel properties, such
as gelation temperature and modulus, can be targeted. In the subsequent sections
background information on self-assembling block copolymers, cell growth scaffolds,
gold nanoparticles, and gene delivery vehicles will be presented to lay the foundation for
the rationale of the thesis work.

Tumor Growth
Suppression
X

Monomer
(10-10 m)

Polymer
(10-9 m)

Nanoassembly
(10-9 - 10-7 m)

Microscopic
Response
(10-6 m)

Macroscopic
Response
(>10-3 m)

X

Figure I-1. The bottom-up rational design of a theranostic nanocarrier (top) and
temperature-responsive gel (bottom). The top nanoassembly is capable of delivering gene
therapeutics to cancerous tissue resulting in suppression of tumor growth. The bottom
depiction represents a system which is forms macroscopic structures in response to
changes in temperature.
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5
Self-Assembled Block Copolymers
Hydrophilic-b-hydrophobic copolymers can self-assemble into advanced
architectures when dissolved in a solvent selective for one block. However, direct
dissolution into a selective-solvent often produces large, inhomogeneous aggregates or
precipitation, and thus an alternate route must be used to obtain self-assembled structures.
An often-used alternative involves the dissolution of the polymer in a common solvent
(i.e. dioxane/water mixture) and subsequent dialysis against a selective solvent (i.e.
water). However this process is tedious and can often take several days to accomplish.
In order to quickly and reversibly form self-assembled structures in aqueous
solution, a large number of research groups have focused on hydrophilic-b-stimuliresponsive (HbS) copolymers.1, 2 In contrast with hydrophilic-b-hydrophobic copolymers
which require indirect dissolution methods, HbS copolymers can be dissolved directly in
water. Stimuli commonly used to induce changes include pH, salt, and temperature.
Most stimuli-responsive block copolymers have been synthesized by RAFT or ATRP
polymerization due to versatility in monomer selection and mild reaction conditions these
techniques offer.
The first successful pH-responsive block copolymers synthesized by aqueous
RAFT polymerization were reported in 2001 by our laboratory.3 A poly(sodium styrene
sulfonate) (PSS) (M22) macroCTA was successfully chain extended with sodium 4vinylbenzoic acid (VBA) (M21) yielding a pH-responsive block copolymer. At low pH,
the carboxylic acid groups of PVBA are protonated rendering the PVBA block
hydrophobic and thus leading to micellization. Because pH is utilized to induce
micellization, association is fully reversible in aqueous solution. The reversible
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micellization monitored by dynamic light scattering (DLS) indicated individual block
copolymer chains (unimers) with hydrodynamic diameters of 8 nm at high pH and
micelles at low pH with hydrodynamic diameters of 38 nm. Other pH-responsive block
copolymers synthesized by RAFT include poly(sodium 2-acrylamido-2methylpropanesulfonate-b-sodium3-acrylamido-3-methylbutanoate) (PAMPS-bPAMBA) (M25-b-M24),4,5 poly(N,N-dimethylacrylamide-b-N,Ndimethylbenzylvinylamine) (PDMA-b-PDMBVA) (M2-b-M18),6 poly(2-vinylpyridineb-4-vinylpyridine) (P2VP-b-P4VP) (M19-b-M20),7, and poly(N,N-dimethylacrylamideb-[N-isopropylacrylamide-s-N-acryloylvaline]) (PDMA-b-(PNIPAM-s-PAVAL)) (M19b-(M5-s-M23)).8
A number of thermoresponsive polymers have been studied as potential
pharmaceutical delivery agents. Most thermoresponsive polymers are synthesized
from N-alkyl acrylamides, the most researched being P(NIPAM) (M19) since it possesses
a lower critical solution temperature (LCST) of 32 °C, close to physiological
temperature, 37 °C. Above the LCST, P(NIPAM) becomes hydrophobic, a result of a
gain in entropy due to the disruption of the water shell associated with the isopropyl
groups of NIPAM. For detailed information, the reader is directed to Appendix I and to
the work of Winnik and coworkers9-12 who have published extensively on the behavior of
conventionally and RAFT-polymerized P(NIPAM). Other thermoresponsive polymers
include poly(N-n-propylacrylamide) (PnPA) (M6) , poly(N-acryloylpiperidine) (PNAP)
(M7), and poly(N-acryloylpyrrolidine) (PNAPy) (M8).
In 2000, Ganachaud and coworkers13 reported the RAFT polymerization of
NIPAM in 1,4-dioxane. Subsequently a large number of reports of RAFT polymerization
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of this monomer in organic media with various CTAs have appeared.14 Using an
appropriate CTA and initiator, we reported the first room temperature RAFT
polymerization of NIPAM directly in water, utilizing a diazo initiator and either a
monofunctional or difunctional chain transfer agent.15 Significantly, this procedure
allows polymerization at temperatures below the LCST of P(NIPAM) and thus prevents
polymer aggregation. In addition we have prepared di- and triblock copolymers by first
polymerizing the hydrophilic monomer DMA (M2) and subsequently chain extending the
resulting macroCTA with NIPAM (M5).15 ABA triblocks and AB diblocks were
synthesized in two steps using a difunctional and monofunctional CTA, respectively.15
The micellization behavior of the block copolymers was studied via DLS and static light
scattering (SLS). It was found that as the NIPAM block length increased, the critical
micelle temperature (CMT) decreased.
Oupicky and coworkers16 reported the temperature-mediated association behavior
of heterobifunctional copolymers in aqueous solution. Poly(ethylene glycol)-bP(NIPAM) (PEG-b-M5) block copolymers were synthesized via organic RAFT
polymerization utilizing a PEGylated CTA. After the successful polymerization of
NIPAM, the thiocarbonylthio moiety of the CTA was reduced using excess hexylamine
and the resulting thiol was then conjugated to maleimide derivatized biotin. The binding
efficiency of biotin with avidin was monitored at temperatures below and above the
LCST of the block copolymer. Above the LCST, it was found that biotin is less
accessible to interact with avidin, while below the LCST biotin is readily available. It is
noteworthy that such temperature-responsive systems allow the selective presentation of
ligands that may be beneficial in biomedical applications. Several other research groups
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including Yusa and Morshima,17 Liu and Perrier,18 and Voit et al.19 have reported
P(NIPAM)-based block copolymers for temperature controlled assembly.
While temperature and pH-responsive micelles have received significant attention
due to their ability to sequester and deliver small molecule hydrophobic drugs, a wide
range of opportunities exist for other self-assembled structures. For example, physical
gels can be formed through intermicellar bridging between adjacent micelles. In the
subsequent section, the potential application of physical gels as cell growth platforms is
described.
Cell Growth Platforms
For many years researchers have cultured cells in order to synthesize biological
products, study metabolic pathways, and test drug efficacy.20 One of the major culture
media is the petri dish, a shallow polystyrene dish rendered hydrophilic through plasma
treatment or other methods.21, 22 The petri dish is often used because it is cheap,
convenient, and established throughout the literature. Despite its advantages, research
suggests that cells grown in a two dimensional environment often exhibit anomalous
behavior and therefore result in incongruous results between in vitro and in vivo
studies.23-28
While the use of petri dishes remains widespread, there is significant research
aiming to develop new three dimensional cell growth platforms. These new materials
aim to replicate the three dimensional environment that surrounds cells in tissues, called
the extracellular matrix (ECM). The major structural component of the ECM, collagen,
has a rod-like structure with a length of approximately 300 nm and a diameter of 1.5
nm.29, 30 The mechanical strength, porosity, and chemical functionality of the
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extracellular matrix provide an environment conducive to cell growth. Mechanical
strength can govern such processes as cell differentiation, migration, organization, and
morphology.31 Porosity can dictate cell migration and the diffusion of nutrients through
the matrix.32 With few exceptions, cells must be anchored to a surface to maintain normal
cell functions. Once anchorage is lost, cells undergo programmed cell death known as
apoptosis. While cells can naturally adhere to certain materials through nonspecific
interactions, ECM adhesion ligands may be incorporated into the material to facilitate
anchoring of specific cells.33
A number of natural and synthetic-based three dimensional matrices which
address the above issues have been developed.33-35 Biologically-derived materials are the
most common; however, problems with immunogenicity, batch consistency, and gelation
procedure have prompted the continued research on synthetic scaffolds.36 Synthetic
polymeric gels are an attractive alternative to naturally-derived materials because of the
wide variety of available functional monomers. For example, Anseth and coworkers
have photopolymerized ethylene glycol-based monomers to obtain gels with tunable
mechanical properties and pore sizes.37 In addition, cell-binding domains were
incorporated into these networks in order to increase cell viability. Though covalently
cross-linked gels have been successfully used as three dimensional cell growth platforms,
the irreversible nature of the network prevents the removal of viable cells. While not an
issue for all cell growth experiments, in certain situations it would be advantageous to
remove viable cells/tissue from the matrix for further studies. Thus researchers have
begun investigating systems which reversibly gel in response to a mild stimulus.
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BAB Physical Gels. Physical gels from BAB triblock copolymers, where the A
block is permanently hydrophilic and the B blocks have stimuli-dependent hydrophilicity,
have been investigated for potential cell growth platforms because of the noncovalent,
reversible nature of the cross-links (Scheme I-1).38-47 Typically, a temperature or pH
sensitive B block is incorporated for cell growth applications.38, 41-43, 45, 47 As illustrated in
Scheme I-1, the morphology depends on both the stimulus and polymer concentration.
The triblock copolymer exists as unimers when both polymer components are soluble.
As a stimulus is applied, the outer B block is rendered hydrophobic and either flower-like
micelles or gels can form. At low concentrations, micelle formation dominates whereas
at moderate to high concentrations of polymer, physical cross-links can form when the
polymer is placed in a solvent selective for the inner block. Physical networks may also
form through the entangling of adjacent micelle coronas.48, 49
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Scheme I-1. The reversible formation of self-assembled structures in aqueous solution
from BAB triblock copolymers where the B block is stimuli-responsive and the A block
is permanently hydrophilic. At low polymer concentration flower-like micelles dominate
whereas at high polymer concentration physical networks form as the result of B blocks
of a single unimer residing in different hydrophobic cores.

The formation of a physical network is dependent on the relative populations of
“loops” and “bridges”.50, 51 The inner block forms a bridge when the outer blocks of a
polymer are incorporated into different hydrophobic domains, while a loop forms when
both blocks of a chain are incorporated into the same hydrophobic domain. Loop
formation is limited by the entropically unfavorable conformational constraints that are
imposed on the system as the inner block attempts to back fold on itself.46, 52-54
Bridge formation may also be entropically unfavorable if the inner block of the
polymer chain must adopt a stretched conformation in order to span between hydrophobic
domains. Thus, bridging is not favorable at low polymer concentrations. Another
structural possibility, dangling chain ends, is limited by the increase in interfacial free
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energy which occurs as the chain end is placed in an incompatible solvent.46, 51 As
previously reported, exchange rates between unimers and micellar structures decrease as
the hydrophobicity of the lipophilic block is increased.55-57 Using Monte Carlo
simulations, the formation of loops, dangling chain ends, and bridges in symmetric BAB
triblock copolymers was studied by Mattice et al.48 The results indicate that the existence
of dangling chain ends in physical gels should decrease as the solvent becomes more
incompatible with the outer block.48 Further theoretical treatments on the mechanism and
driving forces behind the physical gelation of associating polymers may be found in the
literature.58-65
Until recently, research in this area had been limited by techniques available to
produce well-defined amphiphilic triblock copolymers. The advent of controlled/„living‟
free radical techniques offers new routes to obtain polymers of complex architecture with
a wide range of monomers.66-72 In addition, CRP provides narrowly dispersed polymers
of controlled molecular weight. The ability to control the molecular weight of individual
block lengths while maintaining narrow polydispersity affords unique opportunities to
study structure-property relationships of (co)polymers. For this reason, polymers
synthesized via controlled/„living‟ free radical techniques may have numerous high
impact applications in the biomedical field.
Armes et al. have synthesized a number of BAB triblock copolymers via atom
transfer radical polymerization (ATRP) that physically gel in response to changes in pH
or temperature.38, 41-43, 45 Several of the copolymer gels showed promise in applications
such as cell growth scaffolds42 and controlled release substrates.43 For example, polymers
containing either 2-(diisopropylamino)ethyl methacrylate (DPAEMA, M17) or 2-
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(diethylamino)ethyl methacrylate (DEAEMA, M16) pH-responsive B blocks and
methacryloyloxyethyl phosphorylcholine (MPC, M27) a permanently hydrophilic A
block have been synthesized. 38, 43 The P(DPAEMA-b-MPC-b-DPAEMA) block
copolymer forms a free standing gel when the pH is increased above 7.4. While the MPC
block confers biocompatibility to the system, cell viability substantially decreases as pH
deviates from physiological pH (~7.4). Thus, gels formed at pH values higher than 7.4
are not practical. There are similar practical considerations for temperature-responsive
gels which require the gel to be stable at physiological temperatures (37 ºC) while
reverting to the sol state under cell-friendly conditions.
Extensive research has been conducted on NIPAM-based polymers (M5) for
biomedical applications such as cell growth scaffolds due to the lower critical solution
temperature it exhibits at 32 ºC (See Appendix I). While P(NIPAM) has been widely
used in chemically cross-linked polymer gels, the development of reaction conditions for
the controlled polymerization of the monomer opened the door to a new class of
temperature-responsive physical assemblies. In 2000, Ganachaud and coworkers
reported the RAFT polymerization of NIPAM.13 Subsequent work by Convertine and
coworkers led to the synthesis of P(NIPAM) homo- and block copolymers at room
temperature in dimethylformamide 73 and water15.
In 2005 Armes and coworkers synthesized a series of P(NIPAM-b-MPC-bNIPAM) (M5-b-M27-b-M5) copolymers via ATRP.74 However, gel permeation
chromatography (GPC) analyses were not conducted and thus definitive control of the
polymerization could not be stated. In order to determine whether the material could gel,
tube inversion and rheometric tests were performed. An 8 wt% solution increased in
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viscosity from 0.1 Pa∙s-1 to 100 Pa∙s-1 as the temperature was increased from 20 to 50
ºC.74 Tube inversion test indicated the material was capable of forming free standing gels
at elevated temperatures. While these materials have shown promise for 3-D cell growth
applications, the ability to fully characterize the polymers restricts the usefulness because
of the inability to determine batch-to-batch consistency and to draw useful conclusions on
the effect of block lengths on material properties.
In 2009 Sumerlin and coworkers reported the synthesis of temperature and redox
responsive hydrogels based on P(NIPAM-b-DMA-b-NIPAM) (M5-b-M2-b-M5) and
P(NIPAM-b-(di(ethylene glycol)ethyl ether acrylate)-b-NIPAM) (PDEGA).75 A
symmetrical difunctional chain transfer agent was utilized in the synthesis of the
polymers, providing a redox-sensitive trithiocarbonate core. Physically cross-linked
networks formed due to intermicellar bridging of polymer chains (Scheme I-2).75
Subsequently, a primary amine containing small molecule was introduced resulting in
dissolution of the gel due to cleavage of bridges. Introduction of an oxidizing agent
allowed reformation of a gel through the cross-linking of micelles via disulfide linkages.
While rheometric tests were not conducted on the materials and thus conclusions could
not be drawn about the difference in mechanical properties of trithiocarbonate and
disulfide-based gels, the report demonstrates the utility of the chain transfer agent in the
reversible formation of micellar gels. It should be noted that samples with short inner
blocks such as P(NIPAM102-b-DMA123-b-NIPAM102) (Mn=35300 g mol-1) did not form
gels unless greater than 50 wt% polymer was added. Conversely, polymers with
substantially longer inner blocks (P(NIPAM102-b-DMA824-b-NIPAM102) were able to
form gels at approximately 10 wt% polymer.75
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Aminolysis

Physically cross-linked network of
P(NIPAM-b-DMA-b-NIPAM) or
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Scheme I-2. Reversible formation of physically cross-linked redox sensitive gel based on
either P(NIPAM-b-DMA-b-NIPAM) or P(NIPAM-b-PDEGA-b-NIPAM). Structures
apply when the temperature is greater than the LCST.75
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While the previously described examples demonstrate the potential utility of BAB
polymers as cell growth scaffolds, these studies either completely lacked rheological
testing or only had minimal studies. Furthermore, it is difficult to draw conclusions about
the applicability of the in vitro use of these materials because DI H2O was utilized as a
solvent in the majority of cases. Because cells are supported in a saline environment and
it is known that salt affects the behavior of P(NIPAM) and polyzwitterions like PMPC,
testing in salt solutions is needed to draw meaningful conclusions.
ABA physical gels. In contrast with BAB block copolymers which form gels due
to intermicellar bridging, the architecture of AB diblock and ABA triblock copolymers
require an alternate mode of gelation. Several research groups have determined that AB
and ABA block copolymers form physical gels through the packing of micelles (Scheme
I-3).76-85 As illustrated in Scheme I-3, star-like micelles form at low concentration and
ordered or disordered gels form at high concentrations of polymer. Several groups have
demonstrated the importance of the PEO block length and polymer concentration on the
ordering and gelation of such systems.77, 79, 86 For example, face-centered cubic (FCC)
gels require a critical volume fraction (CVF) of 0.74 while body-centered (BCC) gels
require a (CVF) of 0.68.87 Furthermore, Hamley and coworkers reported that crew-cut
micelles were more likely to form FCC gels while hairy micelles were more likely to
form BCC gels.88 As an empirical relationship, Hamley found that FCC lattices formed at
low concentration of polymer when the ratio of the water-soluble block to organicsoluble block (W:O) was < 10. Conversely, BCC lattices formed at high concentrations
or at low concentrations when W:O > 10.87
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Scheme I-3. Stimuli-induced physical gelation of an ABA triblock copolymer.

Historically, most micellar gels have been based on poly(ethylene oxide) (PEO)
diblock copolymers. For example, Jérôme et al. synthesized the CBA triblock copolymer
poly(styrene)-b-poly(2-vinylpyridine)-b-PEO via anionic polymerization. The poly(2vinylpyridine) block was utilized as a pH-responsive block capable of altering gel
properties.89 Given the hydrophobicity of the polystyrene block, gels could not be formed
directly in H2O, but rather required polymer dissolution in DMF and subsequent dilution
with H2O to induce gelation. At acidic pH values, hard gels were formed (1.4 kPa) while
soft, free-flowing gels were formed under basic pH conditions (0.65 kPa).89
Although most biomedically relevant ABA gels contain PEO, recent
advancements in CRP techniques1, 90, 91 have provided a route for synthesizing a diverse
set of stimuli-responsive vinyl-based polymers. For example, Loo et al. prepared a series
of triblock copolymers comprised of poly(styrene) outer blocks and a poly(2-
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hydroxyethyl methacrylate-s-DMAEMA) (M4-s-M15) inner block.92 The triblock
copolymers formed lamellar morphologies in the solid state. When swollen in water, the
copolymers maintained a lamellar nanoscopic morphology, but lost macroscopic
integrity, thus indicating susceptibility to dilution effects.92 Additionally, diblock
copolymers comprised of PHD and polystyrene capable of forming an array of
morphologies (disordered, lamellar, and hexagonally packed cylinders) in response to
temperature were synthesized.93 Swelling characteristics could be tuned by adjusting the
DMAEMA content.93 Although these materials are interesting, gelation does not occur in
biologically relevant conditions.
As described in the above sections, gel properties are highly dependent on
monomer selection, block length, and architectures. Thus the demonstrated ability to
control these requisite properties through the bottom-up design of polymers utilizing the
RAFT technique would represent significant progress over presently available
procedures. Likewise, the rational design of polymers has significant potential to
advance other areas of biomedical research, such as gene delivery.
Gene Delivery Vehicles
The modus operandus of small interfering RNA (siRNA), down-regulation of a
target messenger RNA via the RNA interference (RNAi) pathway, provides a promising
route for treatment of numerous diseases.94, 95 In the RNAi pathway (Scheme I-4), a
double-stranded RNA (or single-stranded RNA which back-folds on itself to form a
“hairpin” duplex) is cleaved into the appropriately sized siRNA effector molecule
(usually 21-23 base pairs) by an enzyme known as DICER. Following cleavage by
DICER, the antisense strand of siRNA is delivered to an assembly of endoribonucleases
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to form a complex known as RISC (RNA-induced silencing complex). RISC containing
the antisense strand of siRNA binds with a messenger RNA (mRNA) containing a
complementary sequence and ultimately cleaves the targeted gene. Thus downregulation of virtually any protein may be achieved by designing and delivering a specific
siRNA sequence to target a specific gene. However, inefficient delivery, cell specificity,
and limited stability of siRNA has limited the potential of this gene therapeutic.96

DICER
Double-stranded RNA

ATP
Argonaute,
Effector molecules
Cleavage of dsRNA
into siRNA by DICER

RNAi-induced
silencing complex (RISC)
Complementary
mRNA

Protein
Expression

Cleaved mRNA

Target mRNA Cleavage Site

Scheme I-4. General mechanism for siRNA-mediated gene silencing via the RNA
interference pathway. A double-stranded RNA is cleaved by an enzyme known as
DICER. The cleaved antisense strand forms a RNA-induced silencing complex (RISC)
which is able to bind and cleave the complementary target mRNA. Cleavage of the
mRNA results in the down-regulation of protein expression.

Given the promise of this therapeutic, a significant emphasis has been placed on
the development of oligonucleotide carriers. While viral carriers offer promise, concerns
over toxicity, cell specificity, and manufacturing costs have prompted the investigation of
non-viral carriers.97-100 Non-viral systems have been conventionally divided into two
general categories, liposome and polymer-based carriers, however inorganic
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nanoparticles are emerging as a useful class of vehicles. Though liposomes meet several
of the prerequisites for effective delivery,98, 101 deficiencies such as partitioning,
physiological instability, and suboptimal pharmokinetics have precluded their widespread
use.102
A number of polymer-based vehicles have been explored for delivery-based
applications including polymer prodrugs,103 micelles,1, 104-106 and nanoparticles107-109.
These carriers are designed to target genes as effectively as viral vectors, while avoiding
non-specific toxicity and immunogenicity issues. In addition, polymeric carriers must
overcome several extra- and intracellular barriers, as delineated in Table I-1.
Overcoming extracellular barriers ensures the gene and carrier have sufficient time,
stability, and specificity to reach the intended tissue. Additionally, the circulation halflife can be increased by designing a carrier with a neutral surface charge and by
increasing the molecular weight to above the renal threshold (30-50 kDa).110 Equally
critical is the ability to overcome intracellular barriers, which permits the gene to be
delivered to the cell and released from the carrier. The development of novel polymers
that can efficiently overcome extra- and intracellular barriers has been heavily pursued by
the research community.
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Table I-1. Extra- and Intracellular Barriers Encountered by Gene Delivery Vehicles.

Extracellular Barriers

Intracellular Barriers

Serum stability

Endosomal release

Sufficient circulation half-life

Cytoplasmic transport

Specific cellular binding

Carriers can reach the intended delivery site either passively or actively. In
passive targeting of cancer tissue, carriers rely on the enhanced permeability and
retention (EPR) effect. 111-118 The EPR effect (Scheme I-5) is a consequence of the poorly
developed vasculature and lymphatic systems found in cancerous tissue. Enhanced
permeation occurs because capillaries around tumors are “leaky” and allow
macromolecules to escape from the vasculature to the interstitium while retention results
from the inability of tumor tissue to remove macromolecules due to poor lymphatic
drainage.111, 119 Because normal tissue does not permit vascular permeation of
macromolecules and is able to sufficiently drain macromolecules through the lymphatic
system, accumulation of macromolecules occurs primarily at the tumor site.
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Scheme I-5. Anatomical characteristics of normal and tumor tissue with respect to the
enhanced permeation and retention effect.

Actively-targeted systems rely on a moiety which recognizes specific cellular
surface features, resulting in the preferential association of the gene carrier with the
desired cell. As illustrated in Figure I-4, actively targeted polymeric carriers have a
targeting moiety and therapeutic material conjugated to a water-soluble polymeric carrier.
Although Ringsdorf originally proposed this model in the 1970s, synthetic limitations at
the time precluded design of such carriers.120 While the model in Figure I-4 depicts
chain-end conjugation of the targeting moiety, functionalization via the side-chain is also
a viable route. Common targeting moieties include folic acid, peptides, proteins,
carbohydrates, aptamers, and antibodies.121 In addition, research indicates that actively
targeted carriers are taken into the cell more efficiently than polymeric carriers lacking

23
targeting ligands.119, 122, 123 Recently, the McCormick group reported the synthesis of an
actively-targeted siRNA progdrug. Briefly, a statistical copolymer of HPMA (M3) and
APMA (M14) was synthesized by RAFT polymerization.124 A fraction of the primary
amine groups from APMA was converted to activated disulfides and subsequently
reacted with a thiolated RNA. The remaining APMA groups were reacted with an NHSactivated folic acid derivative. The resulting polymer could release siRNA under
reducing conditions as demonstrated by gel electrophoresis studies.

Targeting
Moiety
Therapeutic/
Diagnostic

Polymeric
Carrier

Figure I-4. Actively-targeted polymeric prodrug consisting of a hydrophilic
macromolecule with bioconjugated therapeutic and targeting moieties.

Interpolyelectrolyte complexes. While covalent linkages can be employed to
conjugate siRNA to the side-chain and end-group of polymers,125 oligonucleotides are
commonly complexed via electrostatic interactions to polymeric carriers. These polymeroligonucleotide systems, known as interpolyelectrolyte complexes (IPECs), provide
protection against degradative enzymes while increasing the circulation half-life.126, 127
Charge ratio plays an important role in the stability and transfection efficiency of the
IPEC and is described by an N/P ratio, where N and P respectively describe the nitrogen
content from the polycation and the phosphate content from the oligonucleotide.
Negatively charged complexes (N/P < 1) experience electrostatic repulsion with the
anionically charged cell membrane and thus are not readily internalized. Conversely,
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positively charged complexes (N/P > 1) are strongly attracted to cell membranes, and
thus lack cell specificity, leading to uptake of the IPEC in both healthy and diseased
tissue. Charged complexes may also adsorb serum proteins resulting in clearance by
phagocytic cells.128-131 Neutral complexes (N/P=1) circumvent these problems but often
have poor solubility in aqueous solution due to charge neutralization, thus limiting
applications in biological systems.
Hydrophilic-b-cationic (HbC) copolymers offer an attractive alternative to
cationic homopolymers because neutral complexes can be achieved while retaining
water-solubility.1, 126, 128, 129, 132-134 Additionally, the hydrophilic block sterically stabilizes
the complex. Although cationic-b-hydrophilic copolymers can be synthesized by
utilizing macroinitiators, these processes generally lead to ill-defined molecular weights
and broad polydispersity indices (PDIs). Thus, a controlled polymerization technique,
such as RAFT, provides an attractive route to obtain polymeric gene carriers.1
In 2006 our group reported the controlled synthesis of poly(N-2-hydroxypropyl
methacrylamide) (PHPMA, M3),135 a nonimmunogenic biocompatible polymer, and the
subsequent chain extension with a cationic monomer, N-3-dimethylaminopropyl
methacrylamide (DMAPMA, M13). Neutral, water-soluble complexes were formed with
a 43-nucleotide small interfering ribonucleic acid (siRNA).136 Because RAFT
polymerization allows precise control over block length, the effect of HPMA and
DMAPMA degree of polymerization (DP) on complex stability could be studied.
DMAPMA block length appeared to be the major contributing factor in protecting siRNA
from enzymatic degradation.136 Because the absorbance at 260 nm of mononucleotides is
greater than that of oligonucleotides, degradation of siRNA can be easily monitored by
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UV-Vis spectroscopy. As shown in Figure I-5, unbound siRNA rapidly degrades in the
presence of nucleases while the siRNA complexed with P(HPMA258-b-DMAPMA23)
(M3-b-M13) remains stable.136 The initial increase in absorbance of the polymer/siRNA
system is attributed to the presence of a small amount of unbound siRNA.

Figure I-5. Enzymatic degradation of small interfering ribonucleic acid with RNase A in
the presence and absence of P(HPMA258-b-DMAPMA23) (M3-b-M13).132
Further developments by York and coworkers led to the successful design of
targeted siRNA carriers.124, 134 A three-component polymer was synthesized to contain 1)
a hydrophilic, nonimmunogenic block137-139 2) reactive side functionalities and 3) a
cationic block. Components 1 and 2 were achieved by statistically polymerizing HPMA
(M3) and APMA (M14) to form a macroCTA. Chain extension of the macroCTA with
DMAPMA (M13) yielded a [P(HPMA-s-APMA-b-DMAPMA)] carrier which was then
reacted with folic acid activated with N-hydroxysuccinimide. Subsequently, neutral
polymer/siRNA complexes could be selectively delivered to cancerous cell lines over-
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expressing folate receptors. The potential of polymeric-based carriers is evidenced by the
rapid developments in successful delivery of cells. While polymeric gene delivery
vehicles remain a popular choice, promising research has also been conducted with
siRNA loaded Au nanoparticles (AuNPs). These vehicles may provide similar
stabilization as polymeric carriers, while introducing a diagnostic component.
Au nanoparticles. While synthetic and biological polymers are being extensively
explored as carriers, a number of research groups140-146 have concurrently focused on
preformed AuNPs as gene carriers. AuNPs have features which forecast utility in
nanomedicine including availability in a wide variety of sizes, facile modification by a
ligand-exchange process,147-151 and potential as X-ray contrast agents152. Promising
work has been reported recently in which preformed AuNPs are modified with thiolated
oligonucleotides (SH-ONs) via a ligand exchange process.143-146, 153 However, this
method requires the use of modified oligonucleotides capable of chelating to the Au
surface (i.e. thiol) and conditions which limit the number of unexchanged ligands (excess
SH-ONs). Additionally, this method results in a highly anionic surface charge resulting
in the nonspecific adsorption of serum proteins (opsonization) and hence clearance by the
mononuclear phagocytic system (MPS).108, 128-131, 154-157
Nagaski and coworkers utilized PEG110-b-PDMAEMA48 to stabilize preformed
AuNPs and subsequently complex DNA, RNA, and SH-RNA.105, 146, 158, 159 The PEG
block provided a hydrophilic neutral shell while the PDMAEMA (M15) provided
multiple ligands (tertiary amine) for coordination to the Au surface. This carrier offers
two key advantages including the ability to complex unmodified RNA and presentation
of a neutral surface due to the PEG shell. However, the PEG110-b-PDMAEMA48-
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stabilized AuNPs had low binding capacities, with only ~10% of the oligonucleotide feed
capable of complexing to the polymer-stabilized AuNP.146 The poor binding capacity
may be due to a large number of amines coordinated to the Au surface, limiting the
number of RNA complexation sites.
In situ formed AuNPs have not yet been utilized as gene carriers; however, these
materials have promise since they may circumvent binding capacity limitations reported
for preformed AuNPs. Nagaski and Oiishi demonstrated the ability of amine-containing
HbC polymers to reduce Au+3 to Au0 under mild conditions; however, gene complexation
studies were not conducted with these materials and thus comparison with their work on
siRNA complexed AuNPs cannot be made.146, 158-161 The McCormick and Armes groups
have independently demonstrated the use of HbC polymers as dual reductants and
stabilizers. For example, Armes and coworkers synthesized a series of P(MPC-bDMAEMA) (M27-b-M15) 162 via ATRP which were capable of reducing Au+3 to Au0
while stabilizing AuNPs through multivalent interactions between the tertiary amine of
DMAEMA and the Au surface. Control studies indicated a P(MPC) homopolymer
incapable of reducing Au+3 to Au0 while P(DMAEMA) incubated in the presence of Au+3
resulted in the formation of AuNPs. Thus, it was concluded the tertiary amine of the
P(DMAEMA) was needed for the reduction. Further work conducted by Li and Smith in
the McCormick group demonstrated the usefulness of the autoreduction of Au+3 in the
presence of P(DMAEMA) by “locking” self-assembled block copolymers.163, 164 As
illustrated in Scheme I-6, vesicles can be self-assembled from P(DMAEMA-b-NIPAM)
(M15-b-M5) when heated to 50 ºC. Addition of NaAuCl4 resulted in the formation of
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AuNP cross-linked vesicles which remained intact after lowering the temperature to 25
ºC.
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Scheme I-6. Au nanoparticle cross-linking of a self-assembled vesicle comprised of
P(DMAEMA-b-NIPAM) (M15-b-M5).163

With the rapidly growing areas of gene delivery, tissue engineering, and other
biomedical fields, there is an emerging need for polymers which can be tailored for high
performance applications. Recent advancements in RAFT polymerization provide an
unprecedented opportunity to design polymers with specific compositions and
architectures, allowing the delineation of structure-property relationships. In the
subsequent section, fundamental aspects of RAFT polymerization which have allowed
this technique to move to the forefront of biomaterial synthetic methods will be
described.
Controlled/Living Free Radical Polymerization
Significant technological advancements in controlled/living free radical
polymerization (CRP) have allowed for the development of narrowly-dispersed polymers
with complex architectures. In contrast to conventional free radical polymerization, the
rate of termination (Rt) is suppressed in CRP, allowing polymers of controlled
molecular weights and narrow polydispersity to be synthesized.165-168 Quirk and
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coworkers defined the following experimental criteria for classification of a
controlled/living process169:


Polymerization continues until all monomer is consumed.



Mn vs. conversion is a linear function.



The number of polymer chains is constant.



Degree of polymerization can be controlled by reagent stoichiometry.



Narrowly-dispersed polymers are produced.



Telechelic polymers are produced.

Because the rate of termination has a square dependence on the active radical
concentration, the number of termination events in CRP can be limited by introducing an
agent that restricts the concentration of active radicals. For successful control over
molecular weight and to maintain livingness of a radical polymerization, the number of
active chains must be much less than the number of dormant chains. Rp is decreased due
to a reduction in active radicals; as well, the number of termination events is greatly
suppressed, allowing less than 10% chains to terminate during the course of the reaction.
By comparison, over 99% of chains will terminate by either combination or
disproportionation in conventional FRP. Because termination events are limited in CRP,
a number of architectures have been synthesized (Figure I-6) including block, star and
graft copolymers.170, 171
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Figure I-6. Sample of architectures available through controlled/living free radical
polymerization.

Several CRP techniques exist, including iniferter-mediated polymerization
(IMP), stable free radical polymerization (SFRP),172, 173 atom transfer radical
polymerization (ATRP),174, 175 and RAFT polymerization.170, 176 While IMP and SFRP
suffer from many drawbacks including application to a limited number of monomer
families, ATRP and RAFT polymerization have not only successfully controlled the
polymerization of a wide variety of monomer families, but reactions can be conducted
under ambient conditions (aqueous solution, room temperature). RAFT polymerization
was reported concurrently by the CSIRO177, 178 and Michelet179, 180 groups in 1998 and
has since become the most versatile of the CRP techniques. As illustrated in Figure I-7,
the number of papers with the keyword RAFT or MADIX (macromolecular design via
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the interchange of xanthates) has increased significantly since its first report in 1998.181
The utility of RAFT polymerization, along with the demand for well-defined polymers
with specific functionality, has prompted significant research in this area. The
mechanism, chain transfer agent (CTA), kinetics, and polymerization conditions
described below provide a fundamental knowledge-base of RAFT polymerization and
reasons why this method has unparalleled versatility.

# of Articles in Peer Reviewed Journals
with Keyword RAFT or MADIX

300
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Figure I-7. Number of articles appearing in peer-reviewed journals with the keyword
RAFT or MADIX. SciFinder Scholar accessed on November 1, 2009.

The RAFT Mechanism
Initiation. As in conventional free radical polymerization (FRP), a primary radical
source is required to initiate polymerization. In Step Ia of Scheme I-7, an initiating
species (1) decomposes to an active radical. The active radical then adds to monomer
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(M), producing a polymeric radical. A variety of initiators have been employed in RAFT
polymerization, including photolytic, thermolytic, and redox sensitive species.182
Pre-equilibrium. Once a polymeric radical species (2) is formed, it quickly adds
across the double bond of the CTA (3) resulting in an intermediate radical (4). The rate
constant for the addition of (2) across the thiocarbonylthio double bond is denoted by
kadd. The intermediate radical (4) may fragment to release either a radical R-group (5) or a
polymeric radical (2). As shown in Scheme I-7 (IIB-C), the radical species (5 or 2) may
then add across the double bond of a monomer to chain extend the polymer. The preequilibrium stage is completed once all R-groups have fragmented and reinitiated
polymerization to form (6 or 9). The length of the pre-equilibrium stage, and the success
of RAFT polymerization, depends on the relative magnitudes of kadd, k-add, k, and k-In
order to achieve narrowly dispersed polymers, all chains should exit the pre-equilibrium
at approximately the same time.
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Scheme I-7. Proposed mechanism of RAFT polymerization. (I) Initiation provides the
source of free radicals necessary for polymerization. (II) The pre-equilibrium occurs until
all R-groups (5) have been expelled from the intermediate radical and have reinitiated
polymerization to form new propagating chains (7). (III) During the main equilibrium
growing polymeric radicals reversibly add across the macroCTA (6 or 9) to form an
intermediate radical species (8). (IV) Termination generally occurs through the
combination of two radicals.

Main equilibrium. The main equilibrium proceeds via a degenerative chain
transfer mechanism in which polymeric radical species (2or 7) add to the macroCTA (6)
to form an intermediate radical containing polymeric end groups (8). Given the identical
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nature of the polymeric end-groups on the intermediate radical (8), each side has an equal
probability of being expelled as a polymeric radical (2 or 7) capable of propagating with
monomer. The rapid equilibrium between dormant and active species provides each chain
with equal opportunity to grow, thus resulting in narrowly dispersed polymers. While the
number of monomer units which are added between transfer reactions is affected by
several factors including the monomer and CTA concentration, in favorable conditions
less than one monomer is added between transfer reactions.183
Chain termination. Coupling or disproportionation of radicals can occur within
any system containing active propagating radicals. When combination is the predominant
mode of termination, the number of dead chains equals half the number of initiatorderived chains; if disproportionation is the primary mode of termination then the number
of dead chains equals the number of initiator-derived chains. In order to limit termination
events in RAFT polymerization, a high ratio of [CTA]0/[I]0 is utilized to limit the number
of active chains capable of terminating. If appropriate reaction conditions are selected,
the number of dead chains should be < 5%.
Key Aspects of RAFT Polymerization
As with conventional free radical polymerization, RAFT polymerization may be
applied to a wide number of functional vinyl-based monomers. However, key aspects of
RAFT polymerization such as CTA selection must be considered in order to maintain a
well-controlled system. In the subsequent section, consequences of the RAFT
mechanism will be described, including kinetic features which allow the rational design
of block copolymers.
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Chain transfer agent selection. For a given polymerization, certain CTAs will be
more effective in controlling molecular weight and maintaining narrow polydispersity
due to the effects of the Z and R-group.176, 184 As seen in Figure I-8, the CTA has four
key features which determine its effectiveness: the activating “Z” group, a reactive
double bond, a weak single bond, and the “R” leaving group.

Reactive
Double
Bond
S

Activating
Group

Z

C

S

R

Leaving
Group

Weak
Single
Bond

Figure I-8. Key components of a thiocarbonylthio chain transfer agent.

The Z-group serves as a stabilizing or destabilizing agent for the radical adduct as
well as dictates the reactivity of the thiocarbonylthio group towards radical addition.185-187
The Z-group maintains its position at the active chain end throughout the polymerization
and thus affects polymerization kinetics at all conversions. The Z-group must activate the
double bond towards radical addition while balancing the stability of the radical adduct.
If the Z-group provides too much stabilization, retardation can occur due to the slow
fragmentation of the polymer chain from the adduct.176, 188, 189 While bond dissociation
energies have been utilized to predict the stability of a variety of CTA adducts, the
zwitterionic canonical forms must also be considered.190
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As will be discussed below, the R-group must be carefully chosen in order to
minimize an initialization period. The stability of the R-group must be balanced so that it
successfully fragments from the radical adduct and reinitiates polymerization before
adding back to the CTA. While steric bulk, electron withdrawing groups, and radical
stabilizing groups enhance fragmentation from the radical adduct, these factors can
decrease the capacity of the R-group for reinitiation.
Initialization period. The initialization period, also termed the pre-equilibrium,
encompasses the time period during which the R-group of the CTA undergoes
fragmentation and subsequently initiates growth of a new polymer chain. Once all Rgroups have completed step 2b of Scheme I-7, the initialization period is complete.
Klumperman et al. measured initialization times in the polymerization of N-vinyl
pyrrolidone (NVP) via in situ nuclear magnetic resonance (NMR) spectroscopy.191 As
shown in Figure I-9, a linear decrease in CTA and monomer occurs until 275 minutes.
Correspondingly, a linear increase in single monomer adduct is observed for the same
time period. After 275 minutes, all CTA is consumed and a change in slope of monomer
consumption is observed.
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Figure I-9. Concentration profiles of the species involved in the initialization of Nvinylpyrollidone polymerized at 70 ºC in deuterated benzene.191

Pseudo first order kinetics. Assuming a constant number of radical species, the
kinetics of RAFT polymerization may be described by pseudo first order kinetics. In
Equation 1, the rate of polymerization, Rp, is determined by the product of the
concentration of free radicals in solution ([M]), the concentration of monomer ([M]), and
the rate constant of propagation (kp)

−𝑑[𝑀]
𝑑𝑡

= 𝑅𝑝 = 𝑘𝑝 𝑀 𝑀 ∙ = 𝑘𝑝 𝑀

𝑓𝑘 𝑑 𝐼

1
2

𝑘𝑡

(1)

Often, the concentration of free radicals is described by a relationship between
the concentration of initiator ([I]), initiator efficiency (f), the rate constant of initiation
(kd), and the rate constant of termination (kt). As seen in Equation 2, by integrating
Equation 1 with respect to t, [M]0, and [M]t, the monomer concentration at a
predetermined time, yields Equation 3.
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The slope of the pseudo first order kinetic plot, kapp, should remain constant throughout
the polymerization. A negative deviation in slope from the theoretical value indicates
chain termination events thus reducing the number of radicals while a positive deviation
indicates an increase in the number of radicals. Induction periods result in a positive xintercept.
Deviations in the kinetic plot may often be corrected by adjusting the [CTA]0:[I]0
ratio. The concentration of initiator and the rate of initiator decomposition must be
balanced to provide an acceptable rate of polymerization while limiting the number of
dead chains. Well-designed experiments typically have a high ratio of [CTA]:[I] though
polymerizations conducted at ambient temperatures may utilize ratios of 1:1 due to the
low number of radicals generated. The temperature dependent nature of rate constants,
including kd can be expressed empirically by the Arrhenius equation (4)

−𝐸 𝑎

𝑘 = 𝐴𝑒 𝑅𝑇

(4)

where A is the pre-exponential constant, R is the gas constant, Ea is the activation energy
and T is the absolute temperature. As seen from Equation 4, the rate constant will
significantly decrease at low temperatures.
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Control of molecular weight. By utilizing a set ratio of [M]:[CTA] and
controlling conversion () of the polymerization, a predetermined molecular weight may
be targeted. The theoretical molecular weight may be calculated according to Equation 5,
where Mn is the number average molecular weight, [M]0 is the initial concentration of
monomer, [CTA]0 is the initial concentration of CTA, MMW is the molecular weight of
the monomer, and MCTA is the molecular weight of the CTA. Often, MCTA is considered
negligible and not included in Equation 5.

𝑀𝑛,𝑇ℎ𝑒𝑜𝑟 =

𝑀 0 × 𝑀𝑀𝑊 × 𝜌
[𝐶𝑇𝐴]0

+ 𝐶𝑇𝐴𝑀𝑊

(5)

A plot of Mn versus conversion can provide insight to the control of a given RAFT
polymerization. A positive y-intercept and linear slope indicates uncontrolled
polymerization in the early stages of the reaction and can be minimized by choosing
appropriate CTA/monomer pairs and decreasing the concentration of initiator. Molecular
weight overshoot indicates a loss of CTA. A positive deviation in slope, often observed
at high conversions for dithioester mediated polymerizations, is attributed to loss of CTA.
Incorporation of functionality. The facile incorporation of ,  and side-chain
functionality on RAFT-synthesized polymers is perhaps the most significant advantage of
the process. CTAs have been utilized to directly and indirectly introduce chain-end
functionality respectively through the R- and Z-groups.1, 171, 176, 192 Commonly utilized
pre- and post-polymerization chemistries are shown in Scheme I-8. Carbodiimide
chemistry, one of the most frequently used methods to introduce chain-end
functionality,104, 125, 192-198 was utilized by D‟Agosto and coworkers to conjugate N-
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hydroxysuccinimide (NHS) to the carboxylic acid R-group of 2-[[2-phenyl-1thioxo]thio]-propanoic acid.195 Bulmus and coworkers recently reported the synthesis of a
novel trithiocarbonate containing an activated disulfide, allowing facile functionalization
with thiol containing compounds such as bovine serum albumin (BSA).199 A variety of
“click” chemistries (maleimide200, 201, azido202, 203 and thiol-ene204, 205), which are defined
by highly efficient and reagent-specific reactions, have also been utilized to conjugate
biomolecules to RAFT-synthesized polymers.192
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Scheme I-8. Functionalization of the , chain ends of RAFT-synthesized polymers.

Furthermore, RAFT polymerization is highly tolerant to a range of vinyl-based
monomers, allowing the synthesis of an impressive set of side-chain functional materials
often directly in water without requiring protecting group chemistry. As seen in Figure I2 and I-3, styrenics, (meth)acrylates and (meth)acrylamides containing neutral,13, 198, 206-
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anionic,4, 5, 209 cationic, zwitterionic,210, 211 and reactive functionality have been

successfully homo- or copolymerized utilizing RAFT. Of particular significance to the
biomaterial field is the ability to (co)polymerize monomers containing activated esters,
primary amines, and protected thiols. These functionalities allow the facile postpolymerization conjugation of bioactive species to the polymer side chains. Scheme I-9
depicts the simplicity with which a reactive polymer scaffold can be converted to a
polyvalent biomaterial. Activated esters, such as N-acryloxysuccinimide (NAS, M9) and
N-methacryloxysuccinimide (NMS, M10), have been statistically incorporated into a
number of RAFT polymers, providing a nucleophilic reactive site.212, 213 Aminecontaining small molecules are frequently conjugated to backbones using this chemistry
(Scheme I-9) resulting in a polyvalent conjugate. Conversely, a primary amine containing
monomer (i.e. N-3-aminopropyl methacrylamide, APMA, M14) may be incorporated into
the polymer via the polymerization of the acidified monomer; subsequent deprotonation
of the pendent amine groups allows nucleophilic attack on an activated ester small
molecule. By converting the primary amine to its protonated form during
polymerization, CTA aminolysis and hence loss of control is circumvented.214-216
Another facile method to incorporate bioactive compounds is the (co)polymerization of
activated thiols. Bulmus and coworkers reported the first successful polymerization of an
activated thiol, pyridyldisulfide ethyl methacrylate (PDSM, M12), and subsequently
demonstrated the ability to conjugate various small-molecule thiols, including the
tripeptide glutathione.217
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Scheme I-9. Synthesis of polyconjugates via the reaction of activated side chains with
reactive molecules.

The various routes to functionalize end-chain and side-chain groups on RAFT
polymers in addition to the ability to control the molecular weight provide an
unprecedented opportunity for the rational bottom-up design of biorelevant materials.
With the rapidly growing areas of gene delivery, tissue engineering, and other biomedical
fields, there is an emerging need for polymers which can be tailored for high performance
applications. As detailed in the previous sections, recent advancements in RAFT
polymerization provide an unprecedented opportunity to design polymers with specific
compositions and architectures, allowing the delineation of structure-property
relationships. In the ensuing work, RAFT-synthesized polymers will be utilized to
rationally design materials of biomedical relevance.
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CHAPTER II
OBJECTIVES OF RESEARCH
Recent advances in the controlled polymerization of a variety of monomers have
allowed the rational design of functional polymers for biomedical applications. The
McCormick Research Group has been at the forefront of the field, determining
polymerization conditions for a number of monomers classes, including styrenics,
acrylamides, methacrylamides, and acrylates, thus allowing the design of functional
block copolymers with potential applications in therapeutic delivery and diagnostic
testing. In particular, the development of conditions for the controlled synthesis of the
temperature-responsive P(NIPAM) (M5), non-immunogenic, hydrophilic P(HPMA)
(M3), and tertiary-amine containing P(DMAPMA) (M13) has provided an opportunity to
design polymeric platforms for temperature-responsive gels and theranostic delivery
vehicles.
Building on the concept of rationally-designed polymers for biomedical
applications, the overall goals of this research are to: (1) design temperature-responsive
BAB and ABA triblock copolymers for potential applications as scaffolds for cell growth
(2) synthesize polymer-decorated AuNPs capable of binding, protecting, and delivering
siRNA.
Realization of the first goal is contingent upon attainment of objectives 1-6,
which focus on elucidating polymer architecture, block length, and composition on
material properties critical for cell growth applications. The second goal, design of
polymer-decorated AuNPs capable of delivering siRNA, is based on specific objectives
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7-9 involving the synthesis of polymer-stabilized AuNPs and subsequent characterization
of their ability to serve as gene delivery vehicles.
Specific research objectives are to:
(1)

Design well-defined, stimuli-responsive BAB triblock copolymers [A=P(AM)
or P(DMA), B=P(NIPAM)] via RAFT polymerization capable of temperatureinduced gelation.

(2)

Investigate the effects of polymer concentration and block length on the BAB
sol-gel properties including the storage modulus (G‟), loss modulus (G”) and
gelation temperature (Tgel)

(3)

Investigate the effect of salt on the BAB gel mechanical properties, Tgel, and
CGC.

(4)

Design well-defined, stimuli-responsive ABA triblock copolymers
[A=P(DMA), B=P(NIPAM)] via RAFT polymerization capable of temperatureinduced gelation.

(5)

Determine the mechanism of gel formation via small angle x-ray scattering.

(6)

Investigate the effect of A and B block lengths on G‟ and G”.

(7)

Develop a synthetic route for the formation of polymer-stabilized AuNPs with
high siRNA loading capacity.

(8)

Characterize polymer-stabilized AuNPs via dynamic light scattering, small
angle x-ray scattering, UV-Vis spectroscopy, zeta potential, and transmission
electron microscopy

(9)

Investigate the effect of Au reduction conditions on the nanoparticle stability
and oligonucleotide binding capacity.
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(10) Characterize polymer-stabilized AuNP/siRNA complexes by agarose gel
electrophoresis, enzymatic degradation assays, and cell cytotoxicity assays
(11) Evaluate the therapeutic efficacy of siRNA loaded polymer-stabilized AuNPs
through gene knockdown studies.
The research discussed herein has been divided into three sections which are
unified by a central theme of tailoring block copolymers for biotechnological
applications. In the first section, BAB triblock copolymers [A=P(AM) (M1) or P(DMA)
(M2), B=P(NIPAM) (M5)] capable of thermoreversible gelation are synthesized by
RAFT polymerization. The polymers are characterized with respect to their biorelevant
properties including moduli and gelation temperature. In the second section,
temperature-responsive triblock copolymers of an ABA architecture (A=P(DMA),
B=P(NIPAM) are synthesized and characterized. The gelation mechanism is investigated
by temperature-controlled SAXS studies while oscillatory rheometry is utilized to
characterize the mechanical properties. In the third section, a series of P(HPMA-bDMAPMA) (M3-b-M13) diblock copolymers synthesized by RAFT is utilized for the in
situ formation of polymer-stabilized Au nanoparticles (AuNPs) capable of forming
neutral, sterically stable complexes with small interfering RNA. Enzymatic degradation
assays indicate Au carriers provide protection against nucleases while in vitro cell tests
confirm intracellular delivery of siRNA.
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CHAPTER III
EXPERIMENTAL
This chapter describes materials and experimental procedure utilized in research
detailed in this dissertation. The latter has been divided into three sections. In the first
section, the synthesis and characterization of BAB triblock copolymers are described.
The second section provides experimental details on the synthesis and characterization of
ABA triblock copolymers. The in situ formation of polymer-stabilized Au nanoparticles
and subsequent stabilization of siRNA is described in the final section.
Materials
All chemicals were purchased from Fischer or Aldrich at the highest available purity
and used as received unless otherwise noted. N-isopropylacrylamide (NIPAM) (M5) was
recrystallized from hexane. Acrylamide (AM) (M1) was recrystallized three times from
acetone. N,N-dimethylacrylamide (DMA) (M2) was vacuum distilled. 2,2‟-azobis[2-(2imidozolin-2-yl)propane] dihydrochloride (VA-044) and 4,4′-azobis(4-cyanopentanoic
acid) (V-501) were recrystallized from methanol. N-[3-(dimethylamino)propyl]
methacrylamide (DMAPMA) (M13) was purified by vacuum distillation. N-(2hydroxypropyl)methacrylamide (HPMA) (M3) was synthesized according to literature
procedure.218 The difunctional chain transfer agent (CTA) 2-(1-carboxy-1methylethylsulfanylthiocarbonylsulfanyl)-2-methylpropionic acid (CMP) was used
without further purification (gift from Noveon, Inc.). 4-Cyanopentanoic acid
dithiobenzoate (CTP) was synthesized according to literature procedure.3 Structures for
the aforementioned compounds are shown seen in Figure III-1. Type 1 Collagen from rat
tails (high concentration, 8.14 mg/mL) was purchased from BD Biosciences. Gaussia
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Luciferase (Gluc) was synthesized according to previous literature reports.219, 220 The
sense and antisense sequences of siRNA against Gluc are respectively
AGATGTGCAACTTTTGCTACCGCATCT and antisense
AGGAGATGCGGTAGCAAAAGTTGCACATCT. Two strands of a 59-nucleotide (nt)
model small interfering ribonucleic acid (siRNA) against human survivin were
chemically synthesized and labeled with cyanine-3 (Cy3) separately. Unlabeled sense
strand, 5′-AGCCCUUUCUCAAGGACCACCGCAUCU-3′, was purchased from
Integrated DNA Technologies. Cy3-labeled antisense strand, 3′UUUCGGGAAAGAGUUCCUGGUGGCGUAGAGGA-5′ was purchased from
Biosynthesis Inc. A negative siRNA control was purchased from Ambion. A549 cells
(human lung cancer cells), SKOV3 (human ovarian cancer cells), HeLa (human cervical
cancer cells) and KB cells (human nasopharyngeal cancer cells) were purchased from
American type Culture Collection (Manassas, VA). RiboshredderTM RNase Blend was
purchased from Epicenter Biotechnologies. Plasmid pCMV-Gluc and Gaussia luciferase
assay kit were purchased from New England biolab. Celltier 96 Aqueous one solution
cell proliferation assay kit was purchased from Promega.
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Triblock Copolymer Gels
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Figure III-1. Compounds used in the synthesis of temperature-responsive triblock
copolymers and diblock copolymers with requisite properties for the in situ formation and
stabilization of Au nanoparticles.
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Synthesis and Characterization of BAB Triblock Copolymers
General Procedure for the Synthesis of a Difunctional P(NIPAM) macroChain Transfer
Agent
Based on previous kinetic studies,221 polymerization conditions were chosen to
produce a DP=900 or DP=675 NIPAM macroCTA at 90% conversion. The
polymerization was conducted for 10 h at 30 °C in aqueous media at pH 5.0 with an
initial monomer concentration ([M]0) of 0.5 M (Scheme III-1). To synthesize the
P(NIPAM900) macroCTA, the following components were added to a round-bottomed
flask: VA-044 (I1) (10.2 mg, 31.5 μmol), NIPAM (M5) (9.97 g, 88.1 mmol), CMP
(CTA1) (25.1 mg, 88.9 μmol), and deionized water (177 mL). The round-bottomed flask
was sealed with a septum and purged with nitrogen for 30 minutes. After 10 h in a 30 °C
water bath the polymerization was terminated by exposure to air. The P(NIPAM910)
macroCTA (P3) (Mn=103,200, PDI=1.07) was purified via dialysis against an acidic
solution at 4 °C followed by lyophilization. A similar procedure was utilized for the
synthesis of P(NIPAM675) (P1) (Mn=76400, PDI=1.06). Polymer structures are shown in
Figure III-2.
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General Procedure for the Chain Extension of a Difunctional P(NIPAM) macroChain
Transfer Agent with AM
The chain extension of P(NIPAM675) macroCTA (P1) with AM (M1) was
conducted at 27 °C in aqueous media with an initial monomer concentration ([M]0) of 0.5
M (Scheme III-1). Briefly, the following components were added to a round-bottomed
flask: VA-044 (I1) (4.24 mg, 13.1 μmol), P(NIPAM675) macroCTA (1.0 g, 13.1 μmol),
AM (0.74 g, 10 mmol), and deionized water (21 mL). The round-bottomed flask was
septum sealed and purged with nitrogen for 30 minutes. After 1 h in a 27 °C water bath
the polymerization was terminated by exposure to air. P(NIPAM337-b-AM705-bNIPAM337) (P2) (as determined by 1H NMR) was purified via dialysis against an acidic
solution at 4 °C followed by lyophilization. The polymer structure may be seen in Figure
III-2.
General Procedure for the Chain Extension of a Difunctional P(NIPAM) macroChain
Transfer Agent with DMA
The chain extension of P(NIPAM910) macroCTA with DMA (M2) was conducted
at 27 °C in aqueous media with an initial monomer concentration ([M]0) of 0.5 M
(Scheme III-1). To chain extend the macroCTA, the following components were added
to a round-bottomed flask: VA-044 (I1) (3.16 mg, 9.78 μmol), P(NIPAM910) (P3)
macroCTA (1.01 g, 9.78 μmol), DMA (0.88 g, 8.9 mmol or 0.44 g, 4.5 mmol), and
deionized water (17.8 mL or 8.9 mL). The round-bottomed flasks were sealed with septa
and purged with nitrogen for 30 minutes. After 1 h in a 27 °C water bath the
polymerization was terminated by exposure to air. The polymers were purified via
dialysis against an acidic solution at 4 °C followed by lyophilization P(NIPAM455-b-
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DMA210-b-NIPAM455) (P4) (Mn=124,100, PDI=1.06) and P(NIPAM455-b-DMA277-bNIPAM455) (P5) (Mn=130,700, PDI=1.08). Polymer structures may be seen in Figure
III-2.
Size Exclusion Chromatography
Size exclusion chromatography (SEC) was used to determine Mn, Mw, and PDIs
for (co)polymers. Polymers were analyzed on a Viscotek-TDA (0.02 M LiBr DMF
eluent, 1.0 mL/min, 60 °C, Viscotek I-Series Mixed Bed low MW and mid MW columns,
302 nm RI, viscosity, 7 mW 90° and 7° true low angle light scattering detectors). The
dn/dc of each polymer was determined at 632.8 nm in DMF at 60 °C using a Viscotek
refractometer and Omnisec software. The Mn of the inner blocks was determined by
taking the difference between the Mn of the triblock copolymer and homopolymer.
Dynamic Light Scattering of BAB Triblock Copolymers
Dynamic light scattering studies of the block copolymers in aqueous solution
were conducted using a Malvern Instruments Zetasizer Nano Series instrument equipped
with a 22 mW He-Ne laser operating at =632.8 nm, an avalanche photodiode detector
with high quantum efficiency, and an ALV/LSE-5003 tau digital correlator electronics
system. Samples (1 mg/ml) were allowed to dissolve in deionized water overnight. The
sample temperature was increased from 25 ºC to 50 ºC in increments of 1 ºC. Samples
were allowed to equilibrate for 10 min at each temperature increment.
Rheometric Studies of BAB Triblock Copolymers
Rheological measurements of the BAB polymer solutions were performed with a
Rheometrics SR-5000 controlled stress rheometer to determine the gel points, storage
moduli (G‟), and loss moduli (G”) of the temperature-responsive polymers. All
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measurements were performed using a 25 mm cone and plate geometry with an angle of
0.1 radians. An insulated ring was placed around the geometry to prevent water
evaporation. Before performing measurements, the polymers were allowed to dissolve
overnight in either deionized water or 140 mM NaCl/20 mM phosphate buffer. Collagen
gels were prepared according to the alternate gelation procedure provided on the product
specification sheet. Copolymer solutions were presheared for 2 min at a constant applied
shear stress of 5 Pa before dynamic temperature ramp measurements were taken. A
frequency of 1 rad/s was used. Materials were heated with a Peltier plate at a rate of 0.5
°C min-1.
Pulsed Field Gradient Nuclear Magnetic Resonance (PFG NMR) Studies of BAB
Triblock Copolymer Gels
The time-dependent diffusion coefficient of water (Dapp) was determined using
PFG NMR methods. Spectral data were obtained with a Varian UNITYInova 500 MHz
spectrometer using a standard 5mm 2 channel probe equipped with gradients. Selfdiffusion coefficients were determined from the negative slope of a log-attenuation plot
(log ψ versus γ2g2δ2(Δ- δ/3)), where ψ is the echo attenuation, γ is the proton
gyromagnetic ratio, δ is the width of the gradient pulse, g is the magnitude of the applied
field gradient, and Δ is the total diffusion time. The standard Stejskal-Tanner
sequence,222 illustrated in Figure III-3, was utilized with an acquisition time of 0.5 s, a
recycle delay of 5 s, and gradient pulses of 0.8-1.0 ms. The total diffusion time was
varied from 20 to 900 ms, and gradient amplitude ranged from 20 to 80 G/cm to ensure
the signal was attenuated ~80%. The spectral width was 50 kHz and the number of scans
for each spectrum ranged from 8-16. Exponential line broadening was applied prior to
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Fourier transformation of the FIDs. Gradient calibration was performed using a
deionized water standard prior to data collection. Samples consisted of 10 wt% polymer
dissolved in 140 mM NaCl/ 20 mM phosphate buffer pH 7.4.

90 °

180 °
time
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Echo

NMR Signal

time
δ
G

Field Gradient

time
Δ

Figure III-3. The standard pulse sequence used in the pulsed field gradient NMR
experiments.

Confocal Microscopy of BAB Triblock Copolymers
Confocal microscopy samples were comprised of 2.5 x 10-4 M 8-anilino-1naphthalenesulfonic acid (ANS) in a 10 wt% polymer solution (P4 or P5). To prepare
the samples, a stock solution of ANS in acetone was utilized. An appropriate volume of
the stock solution was transferred to a scintillation vial to give 2.5 x 10-7 mol ANS. The
acetone was evaporated under a stream of nitrogen. The triblock copolymer (10 mg) was
added to the scintillation vial and diluted with 1 mL of 140 mM NaCl/ 20 mM phosphate
buffer pH 7.4. The polymer was allowed to dissolve overnight in the dark at 5 °C. A
LSM510 Meta confocal microscope with an excitation wavelength of 488 nm and a
LP505 filter was utilized to image the samples. A heating block was used to control the
sample temperature.
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Small Angle X-ray Scattering of BAB Triblock Copolymers
SAXS profiles were acquired using a seal-tube source, a compact Kratky camera
with a micro-process-controlled hot-stage, and a one-dimensional position-sensitive
detector. Samples were dissolved in DI water overnight in a scintillation vial. Samples
were subsequently loaded into the samples cell and heated to the acquisition temperature
for 30 min before a 1 h SAXS profile was acquired. SAXS traces were acquired under a
positive pressure of helium. Data reduction was carried out as described in previous
reports to desmear absolute intensity.223, 224 CuKa x-rays were employed.
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Synthesis and Characterization of ABA Triblock Copolymers
General Procedure for the Synthesis of a Difunctional P(DMA) macroChain Transfer
Agent
Polymerizations were conducted based on prior literature reports.225 Briefly, the
synthesis of P(DMA) was conducted for 3 h at 25 °C in aqueous media at pH 4.7 with an
initial monomer concentration ([M]0) of 0.5 M (Scheme III-2). A [CTA]0:[I]0 ratio of 5:1
was utilized in each polymerization while three ratios of [M]0:[CTA]0 were utilized in
separate polymerizations, 200:1, 400:1, and 600:1. To synthesize the macroCTA, the
following components were added to a 250 mL round-bottomed flask: DMA (M2), CMP
(CTA1), VA-044 (I1) and DI water to bring the final volume to 140 mL. The pH was
adjusted to a value of 4.7. The flask was sealed with a rubber septum and purged with
nitrogen for 30 min at 5 °C. The flask was then immersed in a 25 °C water bath for 3 h
before quenching by rapid cooling and exposure to oxygen. The P(DMA) macroCTA
was purified by dialysis and lyophilization. P(DMA186) (P6) (Mn=18,400, PDI=1.07),
P(DMA394) (P7) (Mn=39,100, PDI=1.06), P(DMA500) (P8) (Mn=49,600, PDI=1.06) may
be seen in Figure III-3.
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General Procedure for the Chain Extension of a Difunctional P(DMA) macroChain
Transfer Agent
Polymerizations were conducted based on prior literature reports.225 Briefly, the
polymerization was conducted at 25 °C in aqueous media at pH 5.0 with an initial
monomer concentration ([M]0) of 0.5 M. A [CTA]0:[I]0 ratio of 1:1 was utilized in each
polymerization. To chain extend the macroCTA, the following components were added
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to a round-bottomed flask: NIPAM (M5), DMA macroCTA, VA-044 (I1), and DI water
to bring the final volume to 200 mL. The pH was adjusted to a value of 5.0. The
polymerization solutions were purged with nitrogen for 30 min at 5 °C. The flasks were
then immersed in a 25 °C water bath for 1 h before quenching by rapid cooling and
exposure to oxygen. The triblock copolymers were purified by dialysis and
lyophilization. P(DMA93-b-NIPAM213-b-DMA93) (P9) (Mn=42,900, PDI=1.06),
P(DMA93-b-NIPAM372-b-DMA93) (P10) (Mn=55,700, PDI=1.07), P(DMA197-bNIPAM392-b-DMA197) (P11) (Mn=83,700, PDI=1.05), and P(DMA250-b-NIPAM600-bDMA250) (P12) (Mn=117,400, PDI=1.07) can be seen in Figure III-2.
Size Exclusion Chromatography of ABA Triblock Copolymers
SEC was used to determine Mn, Mw, and PDIs for (co)polymers. Polymers were
analyzed on a Viscotek-TDA (0.02 M LiBr DMF eluent, 1.0 mL/min, 60 °C, Viscotek ISeries Mixed Bed low MW and mid MW columns, 302 nm RI, viscosity, 7 mW 90° and
7° true low angle light scattering detectors). The dn/dc of each polymer was determined
at 632.8 nm in DMF at 60 °C using a Viscotek refractometer and Omnisec software. The
Mn of the inner blocks was determined by taking the difference between the Mn of the
triblock copolymer and homopolymer.
Dynamic Light Scattering of ABA Triblock Copolymers
Dynamic light scattering studies of the block copolymers in aqueous solution
were conducted using a Malvern Instruments Zetasizer Nano Series instrument equipped
with a 22 mW He-Ne laser operating at =632.8 nm, an avalanche photodiode detector
with high quantum efficiency, and an ALV/LSE-5003 tau digital correlator electronics
system. Samples (1 mg/ml) were allowed to dissolve in deionized water overnight.
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Temperature was increased from 25 ºC to 50 ºC in increments of 1 ºC. Samples were
allowed to equilibrate for 10 min between measurements.
Rheometric Studies of ABA Triblock Copolymers
Rheological tests of the ABA polymer solutions were performed with a
Rheometrics SR-5000 controlled stress rheometer. A 25 mm cone and plate geometry
with an angle of 0.1 radians was utilized for all measurements. An insulated ring was
placed around the geometry to prevent water evaporation. Before performing
measurements, the polymers were allowed to dissolve overnight in either deionized water
or 140 mM NaCl/20 mM phosphate buffer. In order to ensure polymer were tested
within the linear viscoelastic regime, dynamic frequency sweep experiments were
conducted in triplicate (temperature maintained at 50 ºC with a water bath, 1 Pa). The
storage modulus at 50 ºC was determined as the value obtained at 1 rad/s. Samples were
allowed to equilibrate for 3 min prior to testing. Dynamic temperature ramp tests were
conducted utilizing a Peltier plate to heat the sample at a rate of 1.0 °C min-1. Copolymer
solutions were presheared for 2 min at a constant applied shear stress of 1 Pa before
dynamic temperature ramp measurements were taken at a frequency of 1 rad/s and stress
of 1 Pa. Temperature cycling experiments were conducted using a frequency and stress
of 1 rad/s and 1 Pa, respectively. A Peltier plate was utilized to cycle the temperature
between 25 and 50 ºC at a ramp rate of 50 ºC min-1.
Small Angle X-ray Scattering of ABA Triblock Copolymers
SAXS profiles were acquired using a seal-tube source, a compact Kratky camera
with a micro-process-controlled hot-stage, and a one-dimensional position-sensitive
detector. Samples were allowed to dissolve in DI water overnight in a scintillation vial.
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Samples were subsequently loaded into the samples cell and heated to the acquisition
temperature for 30 min before a 1 h SAXS profile was acquired. SAXS traces were
acquired under a positive pressure of helium. Data reduction was carried per previous
reports to desmear absolute intensity.223, 224 CuKa x-rays were employed.
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Synthesis and Characterization of Polymer-Stabilized Au Nanoparticle/siRNA
Complexes
General Procedure for the Synthesis of a P(HPMA) macroChain Transfer Agent
A P(HPMA) macroCTA was prepared according to previous literature reports.132
Briefly, V-501 (I2) (22.5 mg, 0.08 mmol) and CTP (CTA2) (112 mg, 0.4 mmol) were
used as the primary radical source and chain transfer agent. Polymerizations were
conducted at 70 °C for 3 h in aqueous acetic acid buffer (pH 5.2, 0.27 M acetic acid and
0.73 M sodium acetate) using 1 M HPMA (M3) (11.5 g, 80 mmol). An [M]0/[CTA]0
ratio of 200/1 was utilized while the [CTA]0/[I]0 was kept at 5/1. The final reaction
volume was brought to 80 mL with acetic acid buffer. The round-bottomed flask was
septum-sealed and purged with nitrogen for 45 min prior to polymerization. The
macroCTA was isolated by dialysis (pH 3-4) at 4 °C followed by lyophilization.
P(HPMA70) (P13) (Mn=10,000, PDI=1.05)
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General Procedure for the Chain Extension of a P(HPMA) macroChain Transfer Agent
Block copolymers were prepared according to previous literature reports.132
Briefly, a [M]0/[CTA]0 ratio of 200/1, [CTA]0/[I]0 of 5/1, and 1 M DMAPMA were
utilized in the chain extension of P(HPMA70). Block copolymers were prepared by
adding V-501 (22.5 mg, 0.08 mmol), P(HPMA70) (4.0 g, 0.4 mmol), and 63.7 mL of an
HCl-neutralized 1.25 M DMAPMA (M13) stock solution (16.5 g, 80 mmol) to a 100 mL
round-bottomed flask. The resulting polymerization solution was divided into four
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reaction vessels, septa-sealed, and purged. Flasks were removed from the water bath and
quenched at different time intervals to yield copolymers of varying compositions.
Polymers were purified by dialysis against DI water and subsequent lyophilization. (See
Figure III-5 for polymer structures). P(HPMA70-b-DMAPMA24) (P14) (Mn=15,400,
PDI=1.08), P(HPMA70-b-DMAPMA49) (P15) (Mn=20,100, PDI=1.07), P(HPMA70-bDMAPMA84) (P16) (Mn=27,000, PDI=1.10), P(HPMA70-b-DMAPMA104) (P17)
(Mn=32,000, PDI=1.11) can be seen in Figure III-5.
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utilized for the in situ formation of Au nanoparticles.

Size Exclusion Chromatography of P(HPMA-b-DMAPMA) Copolymers
Polymers were characterized by aqueous SEC (ASEC) utilizing an eluent of 1 wt
% acetic acid/0.10 M Na2SO4 (aq) at a flow rate of 0.25 mL/min at 25 °C, Eprogen, Inc.
CATSEC columns (100, 300, and 1000 Å), a Polymer Laboratories LC1200 UV/vis
detector, a Wyatt Optilab DSP interferometric refractometer (λ=690 nm), and a Wyatt
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DAWN-DSP multiangle laser light scattering (MALLS) detector (λ=633 nm). Absolute
molecular weights and PDIs were calculated using Wyatt OmniSEC software. The dn/dc
measurements were performed with a Wyatt Optilab DSP interferometric refractometer
(λ=690 nm) at 35 °C and determined using OmniSEC software.
1

H NMR Spectroscopy of P(HPMA-b-DMAPMA) Copolymers
Copolymer compositions were determined with a Varian MercuryPLUS 300 MHz

or 500 MHz spectrometer in D2O utilizing solvent suppression with a delay time of 2 s.
DMAPMA block composition of diblock copolymers was determined by 1H NMR
utilizing the relative areas of the methyne proton resonances of HPMA at 3.75 ppm and
the dimethyl proton resonances of DMAPMA at 2.72 ppm.
In situ Formation of P(HPMA-b-DMAPMA) stabilized Au Nanoparticles
AuNPs were synthesized via the in situ reduction of NaAuCl4 to Au0. Briefly,
P(HPMA70-b-DMAPMAx) (X=24, 49, 84, or 104) and 50 mM phosphate buffer (pH 6.0,
103 mL) were added to a round-bottomed flask equipped with a stir bar to give a final
DMAPMA concentration of 1.7 mM. NaAuCl4 was added to the round-bottomed flask to
give either a 100:1, 10:1, or 3:1 ratio of [DMAPMA]0:[NaAuCl4]0. The round-bottomed
flask was sealed with a septum and placed in a 50 ºC oil bath with stirring for 24 h. The
resulting dark red solution was purified by dialysis (50000 mwco tubing) against
deionized water at 4 ºC to remove unbound polymer. Following dialysis, polymerAuNPs were lyophilized, analyzed by thermogravimetric analysis for composition, and
redispersed in 50 mM pH 6 phosphate buffer at a concentration of 1 mM DMAPMA.
A control reduction reaction was conducted utilizing the P(HPMA70) macroCTA
as the reducing agent. The reduction contained 70 M P(HPMA70) and 0.17 mM
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NaAuCl4 in 50 mM pH 6.0 phosphate buffer. The solution was heated at 50 ºC for 3 d
before taking an aliquot and analyzing by UV-Vis spectroscopy.
Preparation of P(HPMA-b-DMAPMA) stabilized Au Nanoparticle oligonucleotide
complexes
Complexes were prepared at N/P ratios of 0.5-5 at room temperature. An
appropriate volume of 1.0 mM DMAPMA HbC-AuNP stock (1-6 L, 1-6 nmol
DMAPMA repeat units) was diluted to 6.6 L utilizing RNase free water. RNApolymer-AuNP complexes (Au nanoplexes) were prepared by adding 1.4 l of a 25 M
survivin siRNA stock (33.9 pmol siRNA, 2 nmol phosphate) to the 6.6 l solution of
HbC-AuNPs. Complexation solutions were immediately vortexed following survivin
siRNA addition and allowed to incubate at room temperature for 30 min.

Gel-loading

buffer (2.5 L) containing 4 L of 0.2% bromophenol blue, 8 M urea, and 1X TBE
buffer (Trisborate-EDTA) was added to samples prepared for gel electrophoresis. The
samples were immediately loaded onto a 1.0% agarose minigel (10 cm x 7 cm) and run
for 30 min at 90 V. After staining by ethidium bromide, the agarose gel was imaged by a
Bio-RAD Universal Hood II CCD camera.
UV-Vis Analysis of Au Nanoparticles
An Agilent 8453 UV-Vis spectrophotometer equipped with a photodiode array
was utilized to measure the absorbance of the P(HPMA70-b-DMAPMAX) reduction
solutions at different time intervals. Samples were prepared by diluting 4 L of the
reaction solution in 400 L of DI water.
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Dynamic Light Scattering and Zeta Potential of Polymer-stabilized Au Nanoparticles
Dynamic light scattering (DLS) and zeta potential measurements of Au
nanoparticles under aqueous conditions were performed using a Malvern-Zetasizer Nano
Series DLS detector with a 22 mW He-Ne laser operating at λ=632.8 nm, an avalanche
photodiode detector with high quantum efficiency, and an ALV/LSE-5003 multiple τ
digital correlator electronics system. Data analysis of DLS measurements was performed
using the CONTIN method. Zeta potential measurements were carried out at a
theranostic concentration of 1 mg/mL in 0.1 M NaCl/ 20 mM Phosphate buffer at pH 7.4
in a zeta folded capillary cells purchased from Malvern Instruments. Both DLS and zeta
potential measurements were performed in triplicate.
Transmission Electron Microscopy
Transmission electron microscopy measurements were conducted using a JEOL
JEM-2100 electron microscope at an accelerating voltage of 200 kV. Samples were
prepared by pipetting 2.5-5.0 μL of a AuNP solution on a carbon-coated copper grid and
subsequently drying over night at room temperature. AuNP diameters were determined
by averaging the size of 100 particles.
Thermogravimetric Analysis
A TA Instrument Q500 series thermogravimetric analyzer was utilized to
determine the composition of polymer-stabilized AuNPs. Lyophilized samples were
loaded in a platinum pan and heated to 600 ºC at a rate of 10 ºC/min under a nitrogen
purge (60 ml/min). Sample composition was determined by comparison of polymer and
polymer-stabilized AuNP degradation profiles.
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Small Angle X-ray Scattering of Polymer-Stabilized Au Nanoparticles
The SAXS profile was acquired using a seal-tube source, a compact Kratky
camera with a controlled hot-stage, and a one-dimensional position-sensitive detector.
The SAXS profile was acquired on lyophilized HbC-AuNPs. SAXS traces were acquired
under vacuum. Data reduction was carried per previous reports to desmear absolute
intensity.223, 224 CuKa x-rays were employed. The diameter of AuNPs, DAu, was
determined by Equation 6

DAu= 2qt-1

(6)

where qt is the value of q where the power-law regions transitions.226 The power-law
regime with an exponent of -4 indicates smooth-surfaced primary particles.227
Enzymatic Degradation Studies of RNA/Au Nanoparticle Complexes
The kinetics of degradation of free and complexed siRNA with RiboshredderTM
RNase blend were obtained using a Varian Carey 50 Bio spectrophotometer, monitoring
at 260 nm (i.e., the max for RNA) in kinetics/time course mode over a time interval of
20 min. P(HPMA258-b-DMAPMA24)-stabilized AuNPs were complexed with a 59
nucleotide anti-survivin siRNA at an N/P of 1.85. This stoichiometry produces a near
neutral Au nanoplex as indicated by agarose gel electrophoresis experiments (see Chapter
IV). Briefly, 10 L (500 pmol siRNA, 29.5 nmol phosphate) of a 50 M anti-survivin
siRNA stock solution was added to 54.5 L (54.5 nmol DMAPMA repeat units) of a 1.0
mM DMAPMA AuNP stock solution. The complex solution was diluted to 1.0 mL (10
mM pH 8.0 Tris, 1 mM EDTA, RiboshredderTM RNase protocol), vortexed, and placed in
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a 1.4 mL quartz cuvette. The spectrophotometer was blanked with a buffer solution
containing 54.5 L of the 1.0 mM DMAPMA AuNP stock solution in order to subtract
absorbance due to the AuNP. The initial absorbance at 260 nm (A260) of the HbCAuNP/siRNA complex solution was recorded. After monitoring the baseline for
approximately 3 min, 3 L of 1 unit/L RiboshredderTM RNase blend was pipetted in the
cuvette and inverted to promote mixing. The resulting solution was monitored
continuously for 20 min at A260 with 536 data points taken per minute.
For the siRNA control, 10 L (500 pmol siRNA, 29.5 nmol phosphate) of a 50
M anti-survivin siRNA stock solution was diluted to 1.0 mL (10 mM pH 8.0 Tris, 1 mM
EDTA, RiboshredderTM RNase protocol), vortexed, and placed in a 1.4 mL quartz
cuvette. The spectrophotometer was blanked with the 10 mM pH 8.0 Tris, 1 mM EDTA
buffer solution. The initial absorbance at 260 nm (A260) of the siRNA solution was
recorded. After monitoring the baseline for approximately 3 min, 3 L of 1 unit/L
RiboshredderTM RNase blend was pipetted in the cuvette and inverted to promote mixing.
The resulting solution was monitored continuously for 20 min at A260 with 536 data
points taken per minute.
Cell Culture
All the cancer cells were maintained and proliferated in folate free RPMI 1640
(Gibco, #27016) cell media supplemented with 10% fetal calf serum (FCS), 100 units
mL-1 penicillin, and 100 g mL-1 streptomycin at 37 °C in 95% air humidified
atmosphere and 5% CO2.
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Toxicity Assay of P(HPMA-b-DMAPMA) stabilized AuNPs
Cell viability tests were performed utilizing a CellTiter 96 Aqueous one solution
cell proliferation assay (Promega). 5000 KB cells were seeded into the 96-well
microplate (Nunclon) one day before treatment. Various amounts of the P(HPMA70-bDMAPMA24)-AuNP stock solution (1.0 mM DMAPMA) were added to the wells
bringing the total volume of medium to 300 L and the concentration of DMAPMA from
0.5 to 100 M. Tests were run in triplicate in 3 separate wells. Cells were cultured for 2
days and subsequently 20 L of CellTiter reagent was added to each well and incubated
for 2 hours before measuring the absorbance at 490 nm using a Synergy2 (BioTek) and
Gen5 software.
Construction of Stably Expressing GLuc Cell Line
KB cells were transfected with pCMV-GLuc (NEB) by DharmaFECT
(Dharmacon) according to protocol. 24 h after transfection, 500 g/mL G418 (Sigma)
was added to the culture for 20 d and the medium was changed every other day. The
surviving colonies which resisted the selection process were carefully collected and
transported into 24-well plates. The positive colonies stably expressing GLuc were
verified using a Gaussia Luciferase Assay Kit (New England Biosciences).
Subsequently, the colonies were amplified, stored and used for siRNA evaluation.
Cell Treatment with AuNP/siRNA complexes for Fluorescence Microscopy
Prior to treatment, KB cells were seeded on cover glasses in a 12-well plate with
600 μL of folate-free RPMI1640 cell media supplemented with 10% FCS and were
cultured for 24 h. Neutral Au nanoplexes (N/P=1.85) were then added to the cell media
to give a 100 nM concentration of siRNA. Cells were incubated with Au nanoplexes for
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40 min. After treatment, the cells were fixed with 4% paraformaldehyde and washed
with phosphate buffered saline (PBS) prior to imaging. The cells were then stained with
4′,6-diamidino-2-phenylindole (DAPI) in 12 μL of mounting gel. The cover glasses were
then placed on pre-cleaned microscope slides for analysis.
Fluorescence Microscopy
A Nikon fluorescence microscope (Eclipse 80i, Plan Fluor 40X/0.75 DIC M/N2
lens) was utilized to image cells. Image-Pro Plus software was used to process images.
Multiple fields were examined for each sample to ensure uniform distribution of
AuNP/siRNA and lipofectamine treatments. Cell treatments were repeated three times to
ensure reproducibility of the observed results.
Cell Treatment with AuNP/siRNA complexes for Gene Down-Regulation Studies
KB cells cells (3 × 104 cells per well) were seeded in 24-well plates (Flow
Laboratories,Inc. McLean,VA) in folate free RPMI 1640 (Gibco, Carlsbad, CA)
supplemented with 10% FCS (HyClone, Logan, UT) 24 h before experiments. Cells
treatments included either free siRNA, neutral Au nanoplexes, or DharmaFECT/siRNA.
In each treatment, cells were incubated with 100 nM GLuc siRNA for 6 h. After this
time period the medium was removed, cells were gently rinsed, and fresh medium was
added.
Gaussia Luciferase Activity Assay
Expression of GLuc was measured according to the manufacture‟s protocol with
minor modification. 15 L of media from stably-expressing KB cell cultures were
transported into a white opaque 96-well plate (Coster, Corning, NY) and mixed with 40
L substrate mixture. Bioluminescence was immediately measured by a Synergy 2
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(BioTeK, Winooski, VT). Subsequent analysis was performed based on Gen5 software
(BioTeK).
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CHAPTER IV
RESULTS AND DISCUSSION
The research discussed herein has been divided into three sections which are
unified by a central theme of the bottom up design of biomaterials. In the first two
sections, the research is directed towards the rational design of triblock copolymers for
physiologically relevant thermoreversible gels. While still focused on the bottom up
design of biomaterials, the central theme of the third section involves gene/diagnostic
delivery vehicles.
The first section concerns the synthesis and characterization of BAB triblock
copolymers containing temperature-responsive outer blocks (NIPAM, M5) and a
hydrophilic inner block (AM, M1 or DMA, M2). The effect of inner block length,
polymer concentration, and solvent on the gel properties is investigated. By adjusting the
polymer concentration, material properties similar to those of collagen are achieved.
Temperature-responsive gels are characterized by rheometry, pulsed-field gradient NMR,
and SAXS.
In the second section, the focus is shifted from BAB to ABA triblock copolymer
gels, in which the hydrophilic outer A blocks are comprised of P(DMA) and the
temperature-responsive inner B block is comprised of P(NIPAM). The effects of
polymer block length and hydrophilic mass fraction on the gel properties are discussed.
Polymer solutions and gels are characterized by rheometry and small angle x-ray
scattering (SAXS).
In the third section, the in situ reduction and stabilization of AuNPs utilizing
RAFT-synthesized P(HPMA-b-DMAPMA) (M3-b-M13) are described. After
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determining the appropriate block length for the formation of stable particles, materials
were characterized by UV-Vis, DLS, TEM, TGA, and SAXS. Subsequently, siRNA was
complexed to polymer-stabilized AuNPs and characterized by agarose gel electrophoresis
and enzymatic degradation studies. Various cancer cell lines were treated with
complexes, and monitored for down-regulation of the targeted gene.
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S ynthesis and Characterization of BAB Triblock (Co)Polymer Gelators
Overview
The ability to synthesize narrowly-dispersed polymers with controlled
architectures has allowed the design of an increasing number of biorelevant structures.
For example, previous work in the McCormick research group focused on the selfassembly of stimuli-responsive di- and triblock copolymers has lead to opportunities in
the drug delivery field. Building on this previous work, we report the synthesis and
characterization of narrowly-dispersed BAB triblock copolymers capable of selfassembling into physically cross-linked gels. The block lengths can be varied in a facile
manner to prepare reversible hydrogel, elastic networks. Poly(N-isopropylacrylamide)
(P(NIPAM)) was chosen as the temperature-responsive outer block because of its
reversible phase transition temperature (32 °C) near physiological conditions (37 °C)228
and studies indicating its cytocompatability229. It is well known that the incorporation of
hydrophilic monomers increases the lower critical solution temperature (LCST) of
P(NIPAM) (M5) and, therefore, the hydrophilic inner block length was carefully selected
to prevent elevation of the LCST to temperatures above 37 ºC.230, 231 Mechanical
properties were targeted to that of collagen, a commonly used material for both two and
three dimensional cell growth matrices. The effects of inner block length, solvent, and
polymer concentration on mechanical properties were investigated. In addition, the
apparent pore sizes of the gels were determined through pulsed field gradient NMR.
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RAFT Synthesis of P(NIPAM-b-AM-b-NIPAM)
Initial studies were conducted utilizing a triblock copolymer comprised of an
P(AM) (M1) inner block and a P(NIPAM) (M5) outer block. In order to obtain a
symmetrical triblock copolymer, a P(NIPAM) macroCTA was synthesized with a
difunctional trithiocarbonate, CMP (Scheme IV-1). The P(NIPAM675) (P1) macroCTA
was analyzed by GPC (Figure IV-1, Table IV-1). After dialysis and lyophilization, P1
was chain extended with AM (M1). Utilizing 1H NMR (Figure IV-1), the conversion of
acrylamide monomer was determined through the ratio of vinyl protons (5.2-6.2 ppm) to
the methyne P(NIPAM674) protons (3.2-4) at t=0 and t=24 h. Approximately 90% of the
vinyl groups were polymerized at t=24 h, yielding a triblock copolymer with the
composition P(NIPAM337-b-AM705-b-NIPAM337) (P2) (Table IV-1). While the Mn and
PDI could not be determined by GPC due to incompatible chromatography conditions,
dynamic light scattering and rheometric tests were conducted in order to determine
whether the material could form self-assembled structures in response to temperature.
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Scheme IV-1. Synthetic route for the preparation of AM (M1) containing BAB triblock
copolymers via aqueous RAFT polymerization.
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Figure IV-1. SEC trace for P(NIPAM675) (P1) macroCTA.
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Table IV-1. Reaction Conditions and Gel Permeation Data for the Synthesized Polymers.

Experimental Structure, Entry #

Time
(h)

Temp
(ºC)

Mn
(kDa)

Mn inner
(kDa)

PDI

P(NIPAM674), P1

10

30

76A

-

1.06

P(NIPAM337-b-DMA705-b-NIPAM375), P2

24

27

126B

50B

N/A

A

As determined by MALLS. B Estimated by the conversion determined from NMR.
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Figure IV-2. H NMR spectrum of a polymerization solution of P(NIPAM674) (P1)
difunctional macroCTA in the presence of acrylamide (M1) monomer at 0 and 24 h.
Monomer conversion was determine by normalizing spectra to the methyne proton of
P(NIPAM) (3.6 ppm) and subsequently comparing the areas under vinylic protons at t= 0
h and t= 24 h.
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Characterization of Temperature-Induced Assemblies of P(NIPAM337-b-AM705-bNIPAM337)
As shown in Figure IV-3, the hydrodynamic diameter (Dh) of P(NIPAM337-bAM705-b-NIPAM337) (P2) gradually decreases as the temperature is increased from 25 to
38 ºC. The decrease in Dh is due to the collapse of the P(NIPAM) block as the
temperature approaches the LCST. As the temperature is increased above 38 ºC, the
polymer assembles into a single species in the size range of micelles with a constant
count rate indicating the material does not precipitate. Because NIPAM homopolymer
precipitates at temperatures above the LCST, the DLS results indicate successful chain
extension with AM. Additionally, the presence of a single population at elevated
temperatures indicates the absence of P(AM) homopolymer impurity. An increase in the
phase transition temperature from 32 ºC to 38 ºC can be attributed to the incorporation of
hydrophilic acrylamide.
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Figure IV-3. Hydrodynamic diameter as a function of temperature for a 0.1 wt% solution
of P(NIPAM337-b-AM705-b-NIPAM337) (P2).
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Given the evidence of triblock copolymer formation, tube inversion tests were
conducted on different wt% polymer solutions heated between 33 ºC and 41 ºC. As
shown in Table IV-2, 2.5-10 wt% solutions were free flowing sols upon inversion within
the temperature range tested. However, a 20 wt% solution formed a free-standing gel
upon inversion at temperatures ≥ 39 ºC. Given these results, rheometric tests were
conducted to probe the mechanical properties. As shown in Figure IV-4, the polymer
solution exists as a low moduli material below the phase transition temperature. As the
temperature is increased, the moduli increase by 5 orders of magnitude which can be
attributed to the formation of an interconnected network.

Table IV-2. Tube Inversion Test Results for Various Weight % Solutions of
P(NIPAM337-b-AM705-b-NIPAM337) (P2). X=Solution. Gel Defined as Free-Standing
Material Upon Tube Inversion.

Wt% Polymer

Temperature (ºC)

2.5

5.0

10

20

33

X

X

X

X

35

X

X

X

X

37

X

X

X

Viscous sol

39

X

X

X

Gel

41

X

X

X

Gel
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Figure IV-4. Dynamic temperature ramp of a 20 wt% gel from P(NIPAM337-b-AM705-bNIPAM337) (P2) dissolved in deionized water. Storage (G‟) and loss (G”) modulus
represented respectively by closed and open symbols.

RAFT synthesis of P(NIPAM-b-DMA-b-NIPAM)
Given the preliminary success of developing a high modulus gel with
P(NIPAM337-b-AM705-b-NIPAM337) (P2), research was extended to a second system
where the inner A block was comprised of DMA (M2). By using DMA as the inner
block, two key advantages over the previous system were expected 1) P(NIPAM-bDMA-b-NIPAM) can be characterized by GPC due to solubility of both blocks in DMF
2) DMA is less hydrophilic than AM (M1), decreasing the chance of shifting the phase
transition above 37 ºC. A difunctional P(NIPAM) macroCTA was utilized in the chain
extension of DMA to yield a symmetrical triblock copolymer in a two-step synthesis.
Scheme IV-2 depicts the synthetic route to achieve a difunctional P(NIPAM) macroCTA
which could be subsequently chain extended with DMA. CMP was chosen due to its
hydrolytic stability under acidic conditions.232 After dialysis and lyophilization, the
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polymers were characterized by triple detection SEC in dimethylformamide (DMF) (see
Table IV-3, Figure IV-5). The dn/dc of each polymer, listed in Table IV-3, was
determined using Omnisec software. The triblock copolymers have well-defined
molecular architectures with polydispersities below 1.10. A large contribution to
mechanical strength of the thermoreversible gels arises from the hydrophobic interactions
of P(NIPAM). Hence, a long outer block length was selected to increase the number of
hydrophobic associations. Moderate inner block lengths were targeted to facilitate
intermicellar bridging at low concentrations while maintaining phase transition
temperatures below 37 °C. The P(NIPAM910) macroCTA (P3) and triblock copolymer
P(NIPAM455-b-DMA210-b-NIPAM455) (P4) closely approach the respective targeted
structures of P(NIPAM900) and P(NIPAM455-b-DMA200-b-NIPAM455).
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Table IV-3. Reaction conditions and gel permeation data for the synthesized polymers.

Time
(h)

Temp
(ºC)

MnA
(kDa)

Mn innerB
(kDa)

PDIA

dn/dc

P(NIPAM910), P3

10

30

103.2

-

1.07

0.074

P(NIPAM455-b-DMA210-b-NIPAM455),
P4

1

27

124.1

20.9

1.06

0.078

P(NIPAM455-b-DMA277-b-NIPAM455),
P5

1

27

130.7

27.5

1.08

0.084

Experimental Structure, Entry #

As determined by triple detection GPC conducted in 0.02 M LiBr DMF eluent. BAs determined
by the difference between the triblock and homopolymer molecular weight.

RI Signal

A

11

12

13

14

15

Retention Volume (mL)

Figure IV-5. SEC traces for the P(NIPAM910) macroCTA (P3) (black), P(NIPAM455-bDMA210-b-NIPAM455) (P4) (green), and P(NIPAM455-b-DMA277-b-NIPAM455) (P5)
(red). A 0.02 M LiBr DMF solution was used as the eluent.
Characterization of Temperature Induced Assemblies of P(NIPAM-b-DMA-b-NIPAM)
The effects of inner block length, polymer concentration, and solvent on the
storage modulus (G‟), and loss modulus (G”), and gel point (Tgel) of the temperatureresponsive polymers were determined through a series of dynamic temperature ramp
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tests. The dynamic temperature ramps of P4 dissolved in deionized water and 140 mM
NaCl/ 20 mM phosphate buffer at different weight percents are shown in Figure IV-6. At
the specific frequency and stress used in the dynamic temperature ramp experiments, the
polymer solutions respond elastically (G‟ > G”) at temperatures below the phase
transition of the P(NIPAM) blocks. Though G‟ is larger than G” at room temperature,
the materials are not deemed gels because of their overall low modulus and ability to
flow under their own weight. As can be observed in Figure IV-6A, no significant
changes in moduli occur for the 2.5 wt% solution dissolved in DI water. The 5.0 wt%
solution of P4 exhibits a slight increase in G” but no significant changes in G‟.
According to Semenov, the formation of intermicellar bridges does not occur until a
critical concentration of flower micelles is reached.59 In addition, the decrease of G‟ to its
initial value at 45 °C suggests negligible bridging at these temperatures. At 7.5 wt%, G‟
increases as the temperature is raised from 37 to 42 °C but falls back to its initial value at
higher temperatures indicating that interconnected flower micelles may form between
these intermediate temperatures; however, bridging is not sufficient for the formation of a
gel network. Previous reports indicate G‟ is related to the lifetime of the junctions and
the stability of the micelle core.49, 50 P(NIPAM) dangling chain ends incur a larger
enthalpic penalty at elevated temperatures because of poor outer block solubility. The
increased enthalpic penalty leads to a shorter lifetime of the dangling chain ends, an
increase in the lifetime of the junctions, and hence an overall higher modulus.
As illustrated in Figure IV-6B, the addition of salt results in a two phase transition
(most notably for solutions ≤ 7.5 wt%). Previously, Bergbreiter, Cremer, and coworkers
reported the two step phase transition of P(NIPAM) which occurs in the presence of
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kosmotropes (water-structure makers) above a certain concentration.233, 234 The LCST of
P(NIPAM) was reported to have a dependence on both anion concentration and anion
type.233-235 The two step transition was also affected by the molecular weight and
concentration of the polymer.234 Hence, the two transitions seen in Figure IV-6B may be
explained by the presence of two kinds of anions, Cl− and PO4−, as well as the two step
phase transition described in the aforementioned literature. Similar trends in the dynamic
temperature ramps were seen for P5 (Figure IV-7).
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Figure IV-6. Storage (G‟) and loss (G”) moduli plotted against temperature for different
concentrations of P(NIPAM455-b-DMA210-b-NIPAM455) (P4) A) in DI water and B) in
140 mM NaCl/ 20 mM phosphate buffer pH 7.4.
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Figure IV-7. Storage (G‟) and loss (G”) moduli plotted against temperature for different
concentrations of P(NIPAM455-b-DMA277-b-NIPAM455) (P5) A) in DI water and B) in
140 mM NaCl/ 20 mM phosphate buffer pH 7.4.
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The gelation temperature (Tgel) of these materials was defined as the crossover
between G‟ and G”. As shown in Figure IV-8a, Tgel decreases as the polymer
concentration increases. The concentration dependence of Tgel corresponds to the
depression in the phase transition temperature of P(NIPAM) with increasing
concentration.228, 236, 237 Because entries P4 and P5 have the same P(NIPAM) block
length, the similarity of Tgel at various concentrations is not surprising. It should be noted
that at 7.5 wt% P5 forms a gel whereas P4 does not. Referring back to Semenov‟s
theory, the loops on P5 should extend further into solution than those of P4, resulting in
overlap and therefore gelation at lower polymer concentrations.59 A series of steady stress
sweep tests indicate that the triblock copolymers begin overlapping at approximately 7.5
to 10 wt% polymer. The addition of 140 mM NaCl/ 20 mM phosphate buffer uniformly
depresses Tgel, resulting in systems that gel at temperature below 37 °C. The depression
of Tgel can be attributed to the disruption of the hydrophobic water shells solvating the
isopropyl groups of P(NIPAM).238
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(G‟Tgel) plotted against the solution concentration of the triblock copolymer. Closed and
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Figure IV-9. The plateau modulus (G‟plateau) as a function of polymer concentration and
solvent conditions. Closed and open symbols represent polymers dissolved in DI water
and 140 mM NaCl/ 20 mM phosphate buffer pH 7.4, respectively. P(NIPAM455-bDMA210-b-NIPAM455) (P4) and P(NIPAM455-b-DMA277-b-NIPAM455) (P5) represented
by squares and triangles respectively.
Figures IV-8-9 indicate that the storage moduli at the gelation temperature (G‟Tgel)
and the moduli at the plateau (G‟plateau) increase with polymer concentration. These
increases can be attributed to the increased number of bridges at higher concentrations as
well as an increased number of hydrophobic interactions. When dissolved in DI water,
P5 exhibits a slightly larger G‟Tgel than P4 over all tested concentrations, suggesting P5
has more bridges connecting hydrophobic domains. The addition of salts to the solvent
results in slight increases in G‟Tgel for P4 and P5. In general, kosmotrope salts disrupt the
ordered water shell which solvates the isopropyl group and therefore decrease the
solubility of P(NIPAM). As stated previously, a decrease in solvent quality should
increase G‟ by decreasing the lifetime of dangling chain ends.
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In order to determine the biological relevance of the material properties, the
mechanical properties of collagen, a commonly used in vitro cell growth platform, were
tested at 37 °C (Figure IV-10, dotted line). Figure IV-10 shows that mechanical
properties similar to collagen can be achieved with the synthesized triblock copolymers
by adjusting the concentration of polymer in solution. When the polymers are dissolved
in DI water, G‟37 °C increases linearly with the semilog plot above a critical concentration
(C*). A dramatic increase in G‟37 °C occurs above C* when the polymer is dissolved in
140 mM NaCl/ 20 mM phosphate buffer. One may explain this trend by referring back to
Semenov‟s theory and basic thermodynamics. Once a critical concentration of micelles is
reached, bridging occurs between hydrophobic domains. The lifetime of dangling chain
ends is decreased because of the increase in interfacial free energy which occurs as the
P(NIPAM) block dangles in the incompatible salt solution. The decreased lifetime of the
dangling chain end results in a stronger network.
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Figure IV-10. Storage modulus at 37 °C (G‟37 °C) plotted against the solution
concentration of the triblock copolymer. Closed and open symbols represent polymers
dissolved in DI water and 140 mM NaCl/ 20 mM phosphate buffer pH 7.4, respectively.
P(NIPAM455-b-DMA210-b-NIPAM455) (P4) and P(NIPAM455-b-DMA277-b-NIPAM455)
(P5) are represented by squares and triangles respectively. The dotted line is included to
show the G‟ value of a typical collagen gel of 0.4 wt%.
The dependence of Dapp on total diffusion time Δ was determined using PFG
NMR spectroscopy. For restricted geometries (such as bridged micelles), the diffusion
coefficient varies with Δ. At short Δ, Dapp will be approximately the same as that of bulk
water, Dfree. As Δ increases, H2O molecules will begin to encounter boundaries, thereby
making Dapp Dfree. At a sufficiently long Δ, Dapp will attain a limiting value.239 The onset
of this limiting time (td) can be used to describe geometric aspects of the material. For
example, the root mean square (RMS) end-to-end distance, r, can be determined using
equation 7,

𝑟2

𝐷𝑎𝑝𝑝 = 6𝑡

𝑑

(7)
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in which Dapp is the apparent diffusion coefficient, td is the time at which the diffusion
coefficient exists, and r is the root mean square end-to-end distance.240
PFG NMR studies were conducted on 10 wt% P4 and P5 in buffer solution.
These concentrations are those at which these synthetic gel mechanical properties at 37
°C closely resemble those of collagen. As evidenced in Figure IV-11, the triblock
copolymers exhibit similar trends. After 40 ms of diffusion time the diffusion coefficient
of water begins to decrease rapidly until a short plateau region is reached at
approximately 400-600 ms. The plateau region suggests that all diffusing species are
experiencing boundaries on this time scale. Using equation 7, the root mean square endto-end distance can be calculated to be approximately 75 μm and 68 μm for the initial
plateau region of P4 and P5, respectively. To properly support cell growth, the surface
features of a scaffold should be smaller than the dimensions of a cell (tens of microns).241
The decrease in Dapp at Δ > 700 ms may be due to background gradients caused by
imperfect shimming and the magnetic susceptibility of the sample. These effects have a
more significant impact on measurements taken at long Δ.242, 243
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Figure IV-11. The apparent diffusion coefficient of water at 37 °C plotted against the
observation time (Δ) for 10 wt% polymer in 140 mM NaCl/ 20 mM phosphate buffer pH
7.4. Closed and open squares represent P(NIPAM455-b-DMA210-b-NIPAM455) (P4) and
P(NIPAM455-b-DMA277-b-NIPAM455) (P5), respectively.
In order to qualitatively investigate the structure of these gels, confocal
microscopy experiments were conducted. The fluorescent probe, ANS, was chosen
because of its increased emission intensity in nonpolar environments.244 Therefore,
fluorescence should intensify at elevated temperatures because of the existence of
hydrophobic domains. As can be seen in Figure IV-12, the fluorescence intensity
increased significantly for P5 when the temperature was increased to 40 °C. The
fluorescent image contains large hydrophobic domains separated by tens of microns in
the X-Y plane. The distance between hydrophobic domains observed in these
experiments may correlate to the RMS distances calculated in the PFG studies. In
addition, a distinct texture can be seen in the differential interference contrast image of
P5 at elevated temperatures indicating morphological changes. Though morphological
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changes were observed for P4 (Figure IV-13) these were less significant than those
observed for P5.

A)

B)

Figure IV-12. Confocal laser scanning microscope images of 10 wt% polymer in 140
mM NaCl/ 20 mM phosphate buffer pH 7.4 with 2.5 x 10-4 M 8-anilino-1-naphthalene
sulfonic acid (ANS), a dye with increased emission intensity in nonpolar environments.
Image of P(NIPAM455-b-DMA277-b-NIPAM455) (P5) at A) room temperature and B) at
40 °C. Each image contains a differential interference contrast image (upper right),
fluorescence image (upper left), and merged image (bottom left).
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A)

B)

Figure IV-13. Confocal laser scanning microscope images of 10 wt% polymer in 140
mM NaCl/ 20 mM phosphate buffer pH 7.4 with 2.5 x 10-4 M 8-anilino-1-naphthalene
sulfonic acid (ANS), a dye with increased emission intensity in nonpolar environments.
Image of P(NIPAM455-b-DMA210-b-NIPAM455) (P4) at A) room temperature and B) at
40 °C. Each image contains a differential interference contrast image (upper right),
fluorescence image (upper left), and merged image (bottom left).

To determine the morphology of solutions and gels, small angle x-ray
measurements were conducted on a 20 wt% polymer solution of P4 at 25 and 50 ºC. At
room temperature, plots of qI(q) vs q, q2I(q) vs q, and I(q) vs q do not show higher order
reflections indicating the absence of hexagonally packed cylinders, lamellae, and BCC
spheres, respectively. Likewise, increasing the temperature to 50 ºC during acquisition of
the profile, did not lead to higher order reflections. Thus, the primary mode of gelation
appears to be due to the intermicellar bridging of polymer chains.
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Figure IV-14. Small angle x-ray scattering on a 20 wt% solution of P(NIPAM455-bDMA210-b-NIPAM455) (P4) at 25 ºC. A) qI(q) versus q plotted to determine the presence
of hexagonally packed cylinders B) q2I(q) versus q plotted to determine the presence of
lamellae C) I(q) vs q plotted to determine the presence of body center cubic spheres.
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Figure IV-15. Small angle x-ray scattering on a 20 wt% gel of P(NIPAM455-b-DMA210b-NIPAM455) (P4) at 50 ºC. A) qI(q) versus q plotted to determine the presence of
hexagonally packed cylinders B) q2I(q) versus q plotted to determine the presence of
lamellae C) I(q) vs q plotted to determine the presence of body center cubic spheres.

While these materials exhibited the appropriate mechanical properties for cell
growth scaffolds, two major factors limited the in vitro application. First, the gels formed
from these materials were opaque, thus limiting visibility of cell morphology (Figure IV16). The ability to visualize the density and shape of cells at different time intervals
provides biologists with important qualitative information about the state of the cell. For
example, healthy endothelial cells generally have a flat oblong morphology while cells
undergoing apoptosis exhibit round, spherical morphologies. Secondly, the materials
exhibit a very rapid transition from the liquid to the sol state. Thus, removal of the cell
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culture from an incubator for visualization under a microscope is problematic. Because
the majority of cells are anchorage dependent, meaning adhesion sites are required for
cell growth, the loss of anchorage sites during the dissolution of the gel can adversely
affect the cells. Despite these disadvantages, advancements towards the design of
physiologically-relevant stimuli-responsive gels were achieved. The mechanical
properties could be tuned through both the control over polymer concentration, inner
block length, and solvent.

Figure IV-16. Photographs of a 20 wt% solution of P(NIPAM455-b-DMA210-bNIPAM455) (P4) at 25 ºC and 50 ºC.
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Synthesis and Characterization of ABA Triblock (Co)Polymer Gelators
Overview
Significant interest in hydrogels has arisen due to their potential applications in
drug delivery and tissue engineering.245-247 Over the past decade CRP techniques have
facilitated the synthesis of complex architectures capable of forming gels such as ABA
and BAB stimuli-responsive block copolymers.237, 248-254 Notably, RAFT polymerization
has proven to be one of the more versatile CRP techniques allowing the controlled
polymerization of a wide variety of monomers under mild reaction conditions directly in
water.91 The synthesis of well-defined amphiphilic polymers is desired because of the
ability of these polymers to form an array of morphologies including gels. P(NIPAM)based assemblies are of particular interest due to the phase transition temperature (32 ºC)
near physiological conditions.255 Diblock (AB) and triblock copolymers (ABA, BAB, and
CBA), in which the A block is permanently hydrophilic and the B and C blocks are either
permanently hydrophobic or stimuli-responsive, can form gels through various
mechanisms. Significant research indicates that AB and ABA block copolymers form
physical gels through the packing of micelles.76-85 Building on the previous work in the
McCormick research group focused on the self-assembly of stimuli-responsive di- and
triblock copolymers as well as the work presented in Section 1 on the assembly of BAB
triblock copolymers, we investigated the effects of polymer block lengths and
compositions on the gel properties of ABA triblock copolymers.
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RAFT synthesis of P(DMA-b-NIPAM-b-DMA)
A difunctional chain transfer agent, (CTA) CMP (CTA1) was utilized to
synthesize symmetrical triblock copolymers in two steps. In the first step (Scheme IV-3),
a hydrophilic monomer (DMA, M2) was synthesized via aqueous RAFT polymerization.
Following dialysis to remove excess monomer and lyophilization, the P(DMA)
macroCTA was chain extended with NIPAM (M5) to form a hydrophilic-b-temperature–
responsive-b-hydrophilic copolymer.
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Scheme IV-3. Synthetic route for the preparation of ABA triblock copolymers via
aqueous RAFT polymerization.
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The molecular weight and PDI of (co)polymers were determined from SEC
(Table IV-4). The low PDIs obtained are indicative of the control exhibited during the
polymerization. A range of molecular weights were synthesized with various hydrophilic
mass fractions (f) (Table IV-4). By increasing the molecular weight why holding the
hydrophilic mass fraction constant, the effect of polymer size versus composition can be
distinguished.

Characterization of Thermo-induced Assemblies
Dynamic light scattering (DLS) experiments of 0.1 wt% solutions were conducted
to verify temperature-induced aggregation in the dilute regime. At 25 ºC, the copolymers
exist as unimers while star-like micelles form at 50 ºC with hydrodynamic radii (Rh)
between 17 and 40 nm (Table IV-4). Each polymer forms stable aggregates as indicated
by a constant count rate. As expected, unimer and aggregate size increases with
increasing polymer molecular weight.
Tube inversion tests indicated that 20 wt% polymer solutions formed transparent
free-standing physical gels at 50 ºC. In order to demonstrate the reversible nature of the
gel, the storage modulus of a 20 wt% sample of P(DMA93-b-NIPAM372-b-DMA93) (P10)
was monitored as the temperature was cycled between 25 and 50 ºC. The storage
modulus (G‟) varies by several orders of magnitude as the temperature is cycled above
and below the phase transition temperature (Figure IV-17). Additionally, the material
responds rapidly and reversibly to changes in temperature. In order to investigate
morphological changes which occur in the concentrated regime, SAXS experiments were
conducted on 20 wt% polymer solutions at various temperatures. As shown in Figure IV-
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18a, at 30 ºC no peaks are observed for P(DMA93-b-NIPAM372-b-DMA93) (P10). A
primary peak at q*= 0.20 nm-1 begins to emerge and intensify as the temperature is
increased to 50 ºC. Weak higher-order reflections indicative of BCC packing (q/q* =
1:√2:√3) are apparent at 50 ºC for P(DMA93-b-NIPAM372-b-DMA93) (P10). The distance
between lattice planes, d100 and d110, at 50 ºC are 44 and 31 nm, respectively.
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Table IV-4. Physical Properties of Copolymers as Determined by Size Exclusion
Chromatography, Dynamic Light Scattering, Small Angle X-Ray Scattering, and
Oscillatory Rheometry.
MnA
(kDa)

PDIA

Rh at 50
ºC (nm)B

D110 at 50
ºC (nm)C

Lattice
TypeD

G’50 ºC of
20 wt%
gel (kPa)E

FF

P(DMA186), P6

18.4

1.07

-

-

-

-

-

P(DMA394), P7

39.1

1.06

-

-

-

-

-

P(DMA500), P8

49.6

1.06

-

-

-

-

-

P(DMA93-bNIPAM213-bDMA93), P9

42.9

1.06

17

26

BCC

3.7

0.43

P(DMA93-bNIPAM372-bDMA93), P10

55.7

1.07

21

31

BCC

3.1

0.33

P(DMA197-bNIPAM392-bDMA197), P11

83.7

1.05

28

38

BCC

2.8

0.47

P(DMA250-bNIPAM600-bDMA250), P12

117.4

1.07

40

44G

NA

2.6

0.42

Experimental
Structure, Entry #

Determined by A SEC, B DLS of a 0.1 wt% solution, C SAXS (d110=2/q*), D ratio of q/q*.
E
Value obtained at 1 rad/s from a dynamic frequency sweep (1 Pa). F f= permanently
hydrophilic mass fraction as determined by SEC. G Lattice does not apply due to disordered
state.
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Figure IV-17. Storage modulus versus time of a 20 wt% sample of P(DMA93NIPAM372-DMA93) (P10) as temperature is cycled between 25 (■) and 50 ºC (▲).
Similar to the molecular weight dependent aggregate size observed in DLS in the
dilute regime, d110 and d100 of polymeric gels increase with increasing polymer molecular
weight (Table IV-3, Figure IV-18B). BCC packing is observed in all gels with the
exception of P(DMA250-b-NIPAM600-b-DMA250) (P12). Unlike the lower molecular
weight polymers which are able to form ordered arrays, P(DMA250-b-NIPAM600-bDMA250) (P12) lacks higher-order reflections indicating a less-defined morphology.
However, the appearance of a primary peak indicates correlation hole effects giving
density fluctuations on the length scale of 44 nm. The long hydrophilic block may
prevent ordered packing through the kinetic trapping of entangled coronas. Given the
approximately equal value of f for P(DMA93-b-NIPAM213-b-DMA93) (P9) and
P(DMA250-b-NIPAM600-b-DMA250) (P12), the differences in ordering may be attributed
to block lengths.
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A)

B)

Figure IV-18. Small angle x-ray scattering of A) 20 wt% P(DMA93-NIPAM372-DMA93)
(P10) at various temperatures and B) a series of 20 wt% copolymers (P9-P12) at 50 ºC.
Red arrows indicate primary peaks and higher order reflections. Intensities are scaled by
a factor of 10 for clarity.
In order to determine the effect of micellar packing on the mechanical properties
of the gel, dynamic frequency sweep tests were conducted at low stress (Figure IV-19).
Each polymer gel forms a hard gel (G‟ > 1 kPa)256 at 50 ºC and displays linear behavior
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in the frequency range studied. These mechanical properties are in the range of
commonly reported values for hydrophobic-b-hydrophilic polymers. Booth and
coworkers reported values of G‟ near 3 kPa for a 16 wt% sample of poly(oxybutylene20b-oxyethylene610) at 50 ºC78 while Derici et al. observed a storage modulus of 100 kPa
for a 30 wt% solution of poly(oxyethylene90-b-oxybutylene10) at 50 ºC77.
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Figure IV-19. Storage modulus data as a function of frequency for 20 wt% P(DMA93-bNIPAM213-b-DMA93) (P9) (■), P(DMA93-b-NIPAM372-b-DMA93) (P10) (●), P(DMA197b-NIPAM392-b-DMA197) (P11) (▲), P(DMA250-b-NIPAM600-b-DMA250) (P12) (▼) gels
at 50 ºC.

The storage modulus decreased from 3.7 to 2.6 kPa as the molecular weight
increased from 43 to 117 kDa (Table IV-4 and Figure IV-19). The inverse relationship of
G‟ and molecular weight may be related to a second trend in which d110 and d100 are
inversely related to G‟. The smaller values of d110 and d100 in the lower molecular weight
systems suggest that smaller aggregates comprise the gels, thus leading to higher surface

108
areas available for entanglements. Conversely, increasing the molecular weight results in
larger values of d100 and d110 thus indicating the gels are comprised of larger aggregates
which possess lower surface area available for interactions. In addition, longer outer
block lengths may increase steric repulsions resulting in a lower G‟. Thirdly, ordering
appears to slightly increase G‟ as noted from the low modulus of the disordered
P(DMA250-b-NIPAM600-b-DMA250) (P12). Lastly, G‟ appears to be independent of the
chemical composition of the triblock copolymer. P(DMA250-b-NIPAM600-b-DMA250)
(P12) and P(DMA93-b-NIPAM213-b-DMA93) (P9) have nearly the same chemical
composition as indicated by f, but have markedly different mechanical strengths. Thus,
lattice size may be adjusted by controlling molecular weight, in turn allowing the tuning
of the mechanical properties.
In order to investigate the relevance of these gels in physiological media, dynamic
temperature ramps were conducted with 15 and 20 wt% gels of P(DMA93-b-NIPAM213-bDMA93) (P9) dissolved in 140 mM NaCl / 20 mM phosphate buffer (pH 7.4). At room
temperature, these polymer solutions are viscous with G” two orders of magnitude
greater than G‟. The onset of the sol-gel transition is observed at approximately 31 and 37
ºC for the 20 and 15 wt% gels, respectively. The concentration-dependent onset of
aggregation is a commonly observed phenomenon in NIPAM containing polymers.255 As
expected for packed micellar gels, mechanical properties increase with increasing
polymer concentration. The moduli of the 15 and 20 wt% samples are within the same
order of magnitude below the phase transition temperature, indicating that differences
due to water content are negligible (Figure IV-20). Conversely, above the gelation
temperature, the storage modulus of the 20 wt% sample is ~2 orders of magnitude greater
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than that of the 15 wt% sample. Thus the increase in moduli with increasing polymer
concentration may be attributed to a higher number of coronal interactions.
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Figure IV-20. Storage (closed symbols) and loss modulus (open symbols) data as a
function of temperature for 15 (●), and 20 (▲) wt% gels of P(DMA93-b-NIPAM213-bDMA93) (P9) dissolved in 140 mM NaCl/20 mM phosphate buffer (pH 7.4).
As with the case of BAB gels investigated, these materials had mechanical
properties and gelation temperatures suitable for cell growth applications. Additionally,
these materials formed optically transparent gels (Figure IV-21) allowing the potential
visualization of cells during culture. However, as demonstrated in Figure IV-21, these
materials rapidly transition from a gel to a free-flowing solution. Thus, removal of the
culture dish for visualization under a microscope might lead to detrimental effects on the
cells.
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Figure IV-21. Photographs of a 20 wt% solution of P(DMA93-b-NIPAM213-b-DMA93)
(P9) at 25 ºC and 50 ºC.
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In Situ Formation of Polymer-Stabilized Au Nanoparticles and Subsequent
Complexation, Stabilization, and Delivery to Cancerous Cells
Overview
In this section we have examined the utility of RAFT-synthesized amphiphilic
polymers for gene/diagnostic delivery applications. One major challenge for synthetic
chemists will be understanding parameters that control self organization of assembled
delivery vehicles, for example micelles, vesicles, interpolyelectrolyte complexes, etc.
Once such morphologies can be constructed reproducibly, delivery and release under
biologically relevant conditions can be pursued in a systematic way.
The specific aim of the research described herein was to develop synthetic
conditions for the in situ formation of polymer-stabilized AuNPs capable of forming
neutral, sterically stable complexes with small interfering RNA. In order to achieve this
goal, a hydrophilic-b-cationic polymer was utilized, in which the amine-containing
cationic block promoted the in situ reduction of Au+3 to AuNPs and provided
complexation sites for siRNA while the nonimmunogenic, hydrophilic block provided
steric stabilization. The reduction conditions, specifically the ratio of amine repeat units
to Au+3, and the DMAPMA block length were critical to the formation of stable AuNPs.
These synthetic conditions also significantly affect the ability of AuNPs to form
electrostatic complexes with siRNA. Once the appropriate reduction conditions were
determined, the ability of polymer-stabilized AuNPs to protect siRNA from nucleases
and deliver RNA was studied.
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Synthesis of Polymer Stabilized Au Nanoparticles
A series of P(HPMA-b-DMAPMA)s (M3-b-M13), synthesized via aqueous
RAFT polymerization,132 (Scheme IV-4) were utilized in the reduction reaction of Au+3
to AuNPs due to requisite properties for the stabilization of AuNPs and complexation
with siRNA. The HPMA block serves as a nonimmunogenic, neutral, hydrophilic, steric
stabilizing block which prevents AuNP aggregation and provides additional steric
protection against nucleases which can degrade siRNA. The neutral surface should also
reduce opsonization and hence clearance by the MPS. The DMAPMA block serves three
roles: 1) promote the in situ reduction of Au+3 to Au0, 2) coordinate to the AuNP surface
via multivalent (N-Au) interactions, and 3) provide cationic sites for the electrostatic
complexation of siRNA. As illustrated in Scheme IV-4, the in situ formation of
hydrophilic-b-cationic stabilized AuNPs (HbC-AuNPs) was conducted at 50 ºC for 24 h
in phosphate buffer (50 mM, pH 6.0) utilizing either a 3/1, 10/1, or 100/1 ratio of
[DMAPMA]/[AuCl4-]0 (1.68 mM DMAPMA repeating units). In order to determine the
optimal block length required for the formation of stable particles, four polymers with the
same HPMA block length (70) but varying DMAPMA block length (24-104) were
utilized in the reduction reactions. To aid in the discussion of results, each reduction
reaction has been assigned an acronym based on the polymer utilized in the reduction
reaction and a subscript referring to the [DMAPMA]/[AuCl4-]0 ratio utilized (Table IV-5).
For example, AuNPs synthesized with P(HPMA70-b-DMAPMA24) (P14) and a 3/1 ratio
of [DMAPMA]/[AuCl4-]0 is assigned the entry P143.

113
S

O

Pi Buffer (50 mM, pH 6.0)
50 ºC, 24 h
1.68 mM DMAPMA
[DMAPMA]0:[AuCl4-]0=3,10, or 100

S
HO
NC

O
HN

O
HN

HO

NH+

P(HPMA-b-DMAPMA)

siRNA

siRNA HbC-AuNP complex
(Au nanoplex)

Hydrophilic-b-Cationic Stabilized
Au Nanoparticle (HbC-AuNP)

Scheme IV-4. Reaction scheme for the formation of small interfering ribonucleic acid/Au
nanoparticle (siRNA/AuNP) complexes (idealized representation). Reduction of AuCl4in the presence of P(HPMA-b-DMAPMA) (M3-b-M13) yielding hydrophilic-b-cationic
AuNPs (HbC-AuNPs). Complexation of siRNA to HbC-AuNPs yielding an
oligonucleotide loaded, polymer-stabilized AuNP (Au nanoplex). Inset illustrates the
multivalent coordination of the DMAPMA repeat units with the AuNP surface.
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Table IV-5. Reduction Reaction Conditions for P(HPMA) (M3) and P(HPMA-bDMAPMA) (M3-b-M13) Copolymers and Resulting Physical Properties.
EntryA

Polymer

[DMAPMA]/[AuCl4- ]0

SPR
BandB

Stable
AuNPsC

P13

P(HPMA70)

P143

P(HPMA70-b-DMAPMA24)

3







P1410

P(HPMA70-b-DMAPMA24)

10







P14100

P(HPMA70-b-DMAPMA24)

100

P153

P(HPMA70-b-DMAPMA49)

3







P1510

P(HPMA70-b-DMAPMA49)

10







P15100

P(HPMA70-b-DMAPMA49)

100

P163

P(HPMA70-b-DMAPMA84)

3




P1610

P(HPMA70-b-DMAPMA84)

10




P16100

P(HPMA70-b-DMAPMA84)

100

P173

P(HPMA70-b-DMAPMA105)

3




P1710

P(HPMA70-b-DMAPMA105)

10




P17100

P(HPMA70-b-DMAPMA105)

100

A

see footnote D

Subscript refers to the [DMAPMA]/[AuCl4- ]0 ratio utilized during the reduction. Determined by B
UV-Vis and C physical observation or through monitoring the count rate obtained by DLS. D
Reductions were conducted utilizing 1.68 mM DMAPMA. For entry P13, which does not contain a
DMAPMA block, reduction conditions were chosen to contain the same molarity polymer and
AuCl4- utilized during the reduction reaction of P14 10.
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Successful reduction of Au+3 to AuNPs was monitored by the appearance of the
surface plasmon resonance (SPR) band at ~520 nm (Table IV-5). For reductions
conducted with a [DMAPMA]/[AuCl4-]0 of 100/1, no SPR band was observed. Based on
Turkevich‟s description of AuNP formation, a critical mass of Au+3 must accumulate
before Au nuclei can form.257 Thus, the low concentration of Au+3 utilized in the
reactions P14-17100 may have prevented Au nanoparticle formation. Increasing the
[DMAPMA]/[AuCl4-]0 to 10/1 and 3/1 lead to the formation of AuNPs as indicated by the
SPR band (Figure IV-22), though not all samples were stable (Table IV-5).

P143
P1410
P153

Absorbance (A.U.)

P1510
P163
P1610

400

500

600

700

800

Wavelength (nm)

Figure IV-22. UV-Vis spectra of the in situ reduction of AuCl4- in the presence of 1.68
mM DMAPMA repeating units (M13) after heating at 50 ºC for 24 h. P(HPMA70-bDMAPMA24) (P14), P(HPMA70-b-DMAPMA49) (P15), P(HPMA70-b-DMAPMA84)
(P16). Subscripts refer to the ratio of [DMAPMA]/[AuCl4-]0 utilized in the reduction
reaction.

P163 and P1610 precipitated several days after the reduction reaction while P173
and P1710 formed large macroscopic precipitates during the reduction reaction. Since the
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concentration of DMAPMA repeating units (1.68 mM) was held constant in each series
of reduction reactions rather than the concentration of polymer, the molarity of HPMA
repeat units varied from 4.9 mM for P14 to 1.1 mM for P17. Because the P(HPMA)
block provides steric stabilization, a reduced concentration could lead to unstable
particles. Figure IV-23 illustrates this concept, in which idealized representations of P14
and P17 stabilized AuNPs are shown with approximately the same number of DMAPMA
repeat units per particle. The red and blue circles represent, respectively, DMAPMA and
HPMA repeat units. Steric stabilization of P17 AuNPs depicted in Figure IV-23 should
be significantly decreased as compared to that of P14 AuNPs due to a significantly less
dense HPMA shell.

P(HPMA70-b-DMAPMA24) (P14)
4 polymer chains
280 HPMA units
96 DMAPMA units

P(HPMA70-b-DMAPMA104) (P17)
1 polymer chain
70 HPMA units
104 DMAPMA units

Figure IV-23. Idealized representation of polymer stabilized Au nanoparticles containing
approximately the same number of DMAPMA repeat units per particle.
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In order to confirm that the DMAPMA units are necessary for AuNP formation, a
control reaction was conducted with P(HPMA70) (P13). In this reaction, 70 M of P13
was incubated with AuCl4- (0.168 mM) at 50 ºC for 72 h. These conditions were chosen
to duplicate the molarity of polymer and AuCl4- utilized in the reduction reaction of
P1410. Absence of the SPR band (Figure IV-24) after the P13 reduction indicates AuNPs
do not form in the absence of DMAPMA.

Absorbance (A.U.)

P13
P1410

400

500

600
700
Wavelength (nm)

800

Figure IV-24. UV-Vis spectra of the in situ reduction reaction of AuCl4- in the presence
of 1.68 mM DMAPMA repeating units (M13) of P(HPMA70-b-DMAPMA24) (P1410) (70
M), after heating at 50 ºC for different time intervals and the in situ reduction reaction
of AuCl4- in the presence of 70 M P(HPMA70) (P13) after heating at 50 ºC for 72 h.
Reduction reactions were performed in 50 mM pH 6.0 phosphate buffer.

P1410 was chosen for further analysis given its aqueous stability for extended
periods of time. Unbound polymer (~14 kDa) was removed from the stabilized AuNPs
by dialysis in 50 kDa MWCO tubing. The remaining deep-red solution was lyophilized,
analyzed by TGA for polymer concentration (Figure IV-25) and subsequently redispersed
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in phosphate buffer (50 mM, pH 6.0) at a DMAPMA concentration of 1.0 mM. The size
of redispersed particles was analyzed by TEM (Figure IV-26). Given the high electron
density of AuNPs in comparison to polymer chains, only Au cores are visible in TEM.
Approximately 100 particles were analyzed utilizing DigitalMicrograph 3.4 Software
(Gatan) to determine an average Au core diameter (DAu) of 6.5 nm (Table IV-6, Figure
26). In order to determine whether the Au cores seen on the TEM micrograph were
comprised of a “cluster” of smaller Au particles or a single large AuNP, small angle x-ray
scattering experiments were conducted (Figure IV-27, Table IV-6). The diameter
determined by SAXS, 7.8 nm, is in good agreement with the diameter determined by
TEM, indicating P1410 AuNPs consist of a single AuNP core.
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Figure IV-25. Percent weight loss of sample as a function of temperature for P(HPMA70b-DMAPMA24) (P14) (---) and P14-stabilized Au nanoparticles (P1410) (---).
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Figure IV-26. A) TEM micrograph of P(HPMA70-b-DMAPMA24)-stabilized AuNPs
(P1410). B) Distribution and cumulative % of Au core diameter sizes.

Figure IV-27. Small angle x-ray diffraction scattering profile for P(HPMA70-bDMAPMA24)-stabilized AuNPs (P1410).
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Table IV-6. Properties of the P(HPMA70-b-DMAPMA24) (P14) and (P1410)-Stabilized
AuNPs P1410.

Sample

P(HPMA70-b-DMAPMA24), P14

P1410

DAu
(nm)A

DAu
(nm)B

Dh
(nm)C


potential
(mv)D

-

-

3.8

19

6.5

7.8

29

-1.1

Determined by A TEM, B SAXS (DAu=2/q), C DLS, D zeta potential.

Key particle characteristics, including neutral surface charge258 and appropriate
hydrodynamic diameter (Dh),259 were characterized by  potential and dynamic light
scattering. As expected, P14 has a positive  potential (19 mV) due to the cationic
DMAPMA repeats which may be present at the slipping plane260 of the unimers (Table
IV-6, Figure IV-28). As illustrated in Scheme IV-4 (inset), coordination of only a few of
the 24 DMAPMA repeat units to the AuNP surface should relegate the cationic charge to
the inner shell while steric repulsions force the HPMA block to the outer shell resulting
in a near neutral  potential. As predicted, the  potential of P1410 (-1.1 mV) is
significantly lower than that of unimers and approaches neutrality.260 Additionally, the
Dh (< 100 nm) has been shown to be critical in the passive delivery of nanoparticles.109,
259

If the unimers were to adopt a random coil confirmation on the surface of the AuNP,

the diameter could be predicted by Equation 8

2𝐷𝑈𝑛𝑖𝑚 𝑒𝑟 + 𝐷𝐴𝑢 = 𝐷𝑃14−𝐴𝑢𝑁𝑃

(8)
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in which DUnimer is the hydrodynamic diameter of unimer and DP14-AuNP is the
hydrodynamic diameter of the P1410 stabilized AuNP. However, DP14-AuNP (29 nm, Table
IV-6, Figure IV-28) is significantly larger than the value predicted by Equation 8 (14.1
nm), indicating polymer chains adopt an extended conformation once bound to the Au
surface, likely due to steric repulsions of neighboring chains. Additionally, unimers are
not detected by DLS in the HbC-AuNP sample, indicating dialysis successfully removes
unbound polymer.
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Figure IV-28. A) Zeta potential of P(HPMA70-b-DMAPMA24) (P14) (▲) and
P(HPMA70-b-DMAPMA24)-stabilized AuNPs (P1410) (■) B) Hydrodynamic diameters of
P(HPMA70-b-DMAPMA24) (P14) (▲) and P(HPMA70-b-DMAPMA24)-stabilized AuNPs
(P1410) (■) measured by dynamic light scattering.
siRNA Complexation and Degradation Studies
To further explore the potential of the HbC-AuNPs as gene delivery carriers,
oligonucleotide complexation studies were conducted with P1410. Traditionally, neutral
interpolyelectrolyte complexes are achieved by mixing oligonucleotides and polycations
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at an N/P ratio of 1. However, in the case of the HbC-AuNPs, a fraction of the
DMAPMA groups interact with the Au surface and thus are not able to bind the
oligonucleotide. Thus, the HbC-AuNPs are expected to require an N/P ratio greater than
1 to form neutral Au nanoplexes. Because  potential measurements are restricted to
determining the surface charge of a species, agarose gel electrophoresis was utilized to
determine the N/P ratio yielding a neutral Au nanoplex. As visualized by gel
electrophoresis in Figure IV-29A, neutral complexes of RNA and P1410 form when an
N/P ratio between 1.5 and 2.0 are utilized. Deviations from this ratio lead to charged
nanoplexes as indicated by the migration of the material on the gel. Further gel
electrophoresis experiments indicated neutral complexes were formed when an N/P ratio
of ~1.85 was utilized, suggesting approximately 54% of the DMAPMA repeat units are
available for complexation with siRNA. While the exact mechanism of AuNP formation
in the presence of amines is unclear,261-264 that changing the ratio of
[DMAPMA]/[AuCl4-]0 from 10/1 to 3/1 led to HbC-AuNPs with poor oligonucleotide
binding capacities (N/P > 15 is required for neutralization, Figure IV-29B). The poor
binding capacity may result from a large fraction of the amines coordinating directly with
gold, leaving few available sites for electrostatic complexation. Thus, the ratio of
[DMAPMA]/[AuCl4-]0 appears to be critical in the design of HbC-AuNP oligonucleotide
carriers.
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Figure IV-29. A) Agarose gel electrophoresis of siRNA (lane 1, control) and P(HPMA70b-DMAPMA24)-stabilized AuNP (P1410) siRNA complexes with N/P ratios from 0.5-3.0
(lanes 2-7). Each lane contains 33 pmol siRNA. B) Agarose gel electrophoresis of tRNA
(lane 1, control) and P(HPMA70-b-DMAPMA24)-stabilized AuNP (P143) siRNA
complexes with N/P ratios from 0.5-15 (lanes 2-7). Each lane contains 33 pmol tRNA.

Once the neutral point was determined, degradation studies were conducted with
RiboshredderTM RNase, a potent mixture of nucleases. In order to demonstrate siRNA
protection, 500 nM siRNA (free or complexed) was exposed to a 30 times excess of
RNase (3 units/mL, ~ 6 g/mL) as compared to serum concentrations (0.2 g/mL)265.
Observation of the hyperchromic effect, an increase in absorbance at 260 nm (Abs260) as
oligonucleotides are degraded to mononucleotides, can be seen in Figure 5. Because
AuNPs absorb at 260 nm, the spectrophotometer was blanked with a buffer solution
containing an identical concentration of P1410 before conducting Au nanoplex
degradation studies. Likewise, the spectrophotometer was blanked with a buffer solution
before conducting the free siRNA degradation study. As indicated by the 30% increase
in Abs260 within 3 min (Figure IV-30), free siRNA is rapidly degraded in the presence of
3 units/mL of RiboShredderTM RNase. Conversely, less than a 3% increase in
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absorbance occurs for neutral Au nanoplexes exposed to the same amount of
RiboShredderTM RNase. The level of siRNA protection, as determined by the relative
rates of enzymatic degradation of free and bound siRNA, increases 100 fold when in the
Au nanoplex form.
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Figure IV-30. Enzymatic degradation of naked and complexed small interfering
ribonucleic acid (siRNA) (500 nM) with RiboshredderTM RNase (3 units/mL) as
monitored by the percent increase in absorbance at 260 nm. Naked siRNA (---) and
neutral P1410 Au nanoplexes ( --- ).
Delivery of siRNA from polymer-stabilized Au Nanoparticles
Before cell delivery studies were conducted, the cytotoxicity of P1410 was
measured using a CellTitr 96 Aqueous one solution cell proliferation assay (Promega)
(Figure IV-31). Cytotoxicity of P1410 AuNPs was found to be negligible in the
concentration range studied. After determining the biocompatibility of AuNP carriers,
several lines of cancer cells (KB, HeLa, SKOV3, A549) were incubated with P1410 Au
nanoplexes (50 nM 59-nucleotide cyanine-3 survivin siRNA134 (Cy3-siRNA)) for 40 min.
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Following incubation, cells were rinsed thoroughly with phosphate buffered saline to
remove free Au nanoplexes and the cell nuclei were stained with 4‟,6-diamidino-2phenylindole (DAPI). As demonstrated in Figure IV-32, all cell lines treated with P1410
Au nanoplexes exhibited red fluorescence, indicating internalization of Cy3-siRNA. KB
cells were also treated with uncomplexed Cy3-siRNA (Figure IV-32) as a negative
control. Negligible fluorescence was observed, indicating the polymer-stabilized AuNP
carrier was required for delivery.
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Figure IV-31. Cytotoxicity of P(HPMA70-b-DMAPMA24) (P1410) stabilized Au
nanoparticles (AuNPs) Arrow points to concentration utilized in gene delivery studies.
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Figure IV-32. Fluorescent microscope images of A) KB cells B) HeLa cells C) SKOV3
cells and D) A549 cells treated with 100 nM cyanine-3 labeled small interfering RNA
(Cy3-siRNA) complexed with P1410. E) As a control, KB cells were incubated with
uncomplexed Cy3-siRNA. Cell nuclei were stained with 4‟-6-diamidino-2-phenylindole
(DAPI, blue). Scale bars= 20 m.

To determine whether siRNA could be released from the AuNP carrier once
internalized, gene down-regulation of a target protein was monitored. KB cell lines
stably expressing Gaussia Luciferase (GLuc) were treated with 100 nM 59-nucleotide
GLuc siRNA (free siRNA and P1410 Au nanoplexes) for 6 h. In addition, cells were
treated with complexes in the presence and absence of serum to ensure opsonization was
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not responsible for the uptake of Au nanoplexes. After incubation, cells were rinsed to
remove free Au nanoplexes and fresh medium was added to the well. Figure IV-33
shows the down-regulation of the target gene when incubated with Au nanoplexes in
comparison to positive and negative controls. Controls included no treatment, treatment
with uncomplexed GLuc siRNA, treatment with nontargeting siRNA control P1410
complexed with DharmaFECT (commercially available transfection agent) and GLuc
siRNA complexed with DharmaFECT. Protein expression levels are down-regulated by
approximately 50% in KB cells treated with P1410 AuNP carriers, indicating internalized
carriers were able to release siRNA. As shown in Figure IV-33, relative luciferase
expression was similar for cells treated with P1410 in the presence and absence of serum.
This indicates protein absorption to AuNP surfaces does not dictate the successful
internalization of the carrier as is the case with SH-siRNA coated AuNPs.143-145
In conclusion, a rationally designed oligonucleotide delivery vehicle was
developed from narrowly-dispersed, RAFT-synthesized polymers. A series of P(HPMAb-DMAPMA)s provided requisite functionality for the in situ formation of AuNPs. The
stability of the AuNPs depended on the DMAPMA block length and the
[DMAPMA]/[Au]0 ratio utilized during the reduction reaction. The hydrodynamic
diameter of P1410 stabilized AuNPs (29 nm) and potential (-1.1 mV) values indicate
cationic DMAPMA units are located near the Au surface while HPMA is presented at the
surface of the P1410 AuNP. Complexation studies indicate neutral Au nanoplexes can be
formed with over half of the P1410 DMAPMA repeat units available for siRNA binding.
Neutral Au nanoplexes protected siRNA against enzymatic degradation and were
successfully delivered to a variety of cancerous cell lines. Compared to other AuNP
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systems which require opsonization-based uptake,143-145 the current platform can be
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efficiently delivered in the absence of serum proteins.
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Figure IV-33. Relative luciferase expression in KB cells 24 h after treatment with 100
nM siRNA. siRNA control (DharmaFECT and a nontargeting siRNA) serves as a
negative control for the specificity of Gaussia Luciferase siRNA (GLuc). GLuc siRNA
(uncomplexed) serves as a negative control for delivery. Dharma/GLuc siRNA (GLuc
siRNA complexed with DharmaFECT) serves as a positive control for delivery.
GLuc/AuNP, no serum and GLuc/AuNP, serum were neutral complexes of P1410 and
GLuc siRNA treated in the presence and absence of serum, respectively. Error bars
represent the standard deviation from 5 independent tests run in triplicate.
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CHAPTER V
CONCLUSIONS
Synthesis and Characterization of BAB Triblock (Co)Polymer Gelators
Temperature-responsive BAB block copolymers capable of forming physical gels
under physiological conditions were synthesized via aqueous RAFT polymerization. The
use of a difunctional trithiocarbonate CTA facilitated the two-step synthesis of welldefined BAB copolymers with symmetrical outer blocks. The outer B blocks of the
triblock copolymers consisted of P(NIPAM) (M5) and the inner A block consisted of
either P(AM) (M1) or P(DMA) (M2). While BAB triblock copolymers containing
P(AM) inner blocks were capable of forming gels, the material could not be fully
characterized with respect to molecular weight and PDI due to incompatible
chromatography conditions. To address this issue P(DMA) was utilized in place of
P(AM) as a hydrophilic block.
Copolymers comprised of P(NIPAM-b-DMA-b-NIPAM) formed physical gels
above the phase transition temperature of P(NIPAM) at concentrations as low as 7.5 wt%
copolymer. Mechanical properties similar to those of collagen (G‟= ~200 Pa), a naturally
occurring polypeptide used as a three dimensional in vitro cell growth scaffold, have been
achieved utilizing reversibly associating polymers. The mechanical properties of the gels
as a function of solvent, polymer concentration, and inner block length were investigated.
The addition of salt to the aqueous solvent resulted in a depression of Tgel and an increase
in G‟37 ºC. Mechanical properties (G‟Tgel, G‟37 ºC) increased linearly on a semi-log plot as a
function of polymer concentration. While inner block length affected the minimum
polymer concentration required for gelation, mechanical properties only differed slightly
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when dissolved in DI water whereas negligible differences were noted when polymers
were dissolved in pH 7.4 buffer.
Synthesis and Characterization of ABA Triblock (Co)Polymer Gelators
Narrowly-dispersed, temperature-responsive acrylamido-based triblock
copolymers capable of self-assembling into star-like micelles and ordered gels have been
synthesized via aqueous RAFT polymerization. In dilute solution, star-like micelles
formed with Rh values between 17 and 40 nm depending on the polymer molecular
weight. Hard gels formed when solutions containing 20 wt% polymer were heated to 50
ºC. SAXS experiments indicated that BCC ordering occurs in gels containing lower
molecular weight polymers. As d100 and d110 decreased, the mechanical properties
increased due to an increase in micellar surface area available for entanglement.
P(DMA250-b-NIPAM600-b-DMA250) (P12), the largest polymer, exhibited no higher order
reflections in the gel state which may be attributed to the kinetic trapping of entangled
micelles. Dynamic temperature ramp studies of P(DMA93-b-NIPAM213-b-DMA93) (P9)
dissolved in physiologically relevant media indicated that hard gels form just prior to
reaching 37 ºC at both 15 and 20 wt%. In conclusion, this research demonstrated the
ability to tune mechanical properties and ordering of thermoreversible ABA gels through
the variation of polymer hydrophilic mass fraction and polymer molecular weight.
In situ Formation of Polymer-Stabilized Au Nanoparticles and Subsequent Complexation,
Stabilization, and Delivery to Cancerous Cells
A facile procedure for the synthesis of polymer-stabilized AuNPs which are
capable of forming neutral, sterically stable complexes with siRNA was developed. The
amine-containing cationic block of P(HPMA-b-DMAPMA) (M3-b-M13) was utilized to
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promote the in situ formation of AuNPs and subsequently bind small interfering RNA
while the nonimmunogenic, hydrophilic block provided steric stabilization. The
DMAPMA block length utilized in the reduction reaction was found to be critical for the
production of stable AuNPs. Within the series studied, polymers containing shorter
DMAPMA block lengths (24 and 49) provided better particle stabilization than polymers
containing longer DMAPMA block lengths (84 vs. 105).
In addition to the DMAPMA block length, the ratio of [DMAPMA]/[Au+3]0 was
critical to the successful development of a AuNP siRNA carrier. As indicated by
negligible absorbance at 520 nm, reduction reactions utilizing a 100/1 ratio of
[DMAPMA]/[Au+3]0 did not produce AuNPs. Reduction reactions which utilized either a
3/1 or 10/1 ratio of [DMAPMA]/[Au+3]0 led to the formation of AuNPs, while the
particles formed with a 10/1 ratio had a much higher siRNA binding capacity than those
formed with a 3/1 ratio.
P(HPMA70-b-DMAPMA24) (P1410) was analyzed for its ability to protect and
deliver siRNA given its solution stability and high oligonucleotide binding capacity.
Kinetic degradation profiles were measured for siRNA in the presence and absence of
P1410. The neutral P1410 siRNA complex exhibited ~100 fold protection as compared to
free siRNA. Delivery of Cy3 labeled siRNA from P1410 to KB, Hela, SKOV3, and A549
cells was confirmed by fluorescence microscopy. Delivery of GLuc siRNA complexed
to P1410 was further confirmed by monitoring relative luciferase expression of treated
and untreated cells. Protein expression levels were down-regulated by approximately
50% in KB cells treated with P1410 AuNP carriers, indicating internalized carriers were
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able to release siRNA. The presence of serum did not dictate delivery efficiency,
indicating opsonization was not the cause of cellular uptake.
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CHAPTER VI
RECOMMENDATIONS FOR FUTURE RESEARCH
In the years immediately following the discovery of RAFT polymerization, the
majority of research was focused on mechanistic studies and development of appropriate
polymerization conditions. Since then, a wide range of monomers, CTAs, and solvents
have been utilized in the controlled synthesis of polymers.14, 266, 267 With the ability to
control the polymerization of a diverse set of monomers, unprecedented opportunities
have opened. For example, room temperature polymerizations conducted in aqueous
media15 provide a facile route for the modification of proteins while still retaining tertiary
structures.192 Novel functional monomers, such as glyco-,192, 268, 269 boronic acid,270-272
and amino-based vinyl monomers,273, 274 provide opportunities for the synthesis of
biorecognizable polymers. For example, Fukuda and coworkers synthesized galactose
and mannose-modified RAFT copolymers capable of stabilizing AuNPs and inducing
protein specific aggregation.268
Regarding the research presented in this dissertation, several nano- and
biotechnology opportunities exist. For example, self-assembled structures can be used as
templates for patterned nanomaterials. As shown in Scheme VI-1, a polymer comprised
of a stimuli-responsive block and a hydrophilic-statistical-reactive block can be
assembled into a nanoporous template. After cross-linking reactive functionality in the
shell of the micelles, core removal is facilitated by the cleavable moiety incorporated
along the polymeric backbone.
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Scheme VI-1. The assembly of a [(hydrophilic-statistical-functional)-b-stimuli
responsive)] polymer with a cleavable core into a face centered cubic nanoporous
template. Following shell cross-linking and core cleavage, a nanoporous material is
obtained. Blue area represents a cross-linked network while black circles represent pores
formed through the removal of stimuli-responsive cores.

AuNPs can also be employed as templates for complex architectures.275, 276 For
example, the Au cores of poly(hydrophilic-b-cationic)-stabilized-AuNP/RNA complexes
can be removed by adding aqua regia or cyanide, leaving a polyelectrolyte complex.276
The size of polyelectrolyte complexes formed with HbC polymers and RNA is dictated
by the N/P ratio and polymer block lengths (Scheme VI-2).126, 127, 132 Conversely,
utilizing HbC-stabilized AuNPs as a template for polyelectrolyte complexation allows an
alternate method to control the size of the complex. Additionally, this route would
provide a means to synthesize shell or core cross-linked structures which lack responsive
groups and thus otherwise might not assemble.
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Scheme VI-2. A) Traditional polyelectrolyte complex formed between a hydrophilic-bcationic polymer and siRNA. B) A templated siRNA complex formed by complexation
of siRNA to a hydrophilic-b-cationic polymer-stabilized AuNP followed by Au core
dissolution.
While the ability of amine-containing polymers to reduce Au+3 to Au has been
established, several parameters involving this process remain unexplored. The research
presented in this dissertation touched on the effect of the N/Au ratio on stable AuNP
formation. However, further studies need to be conducted to obtain a fundamental
understanding of the processes occurring during AuNP formation. Key parameters which
should be further studied include the effects of hydrophilic block length, amine-pendent
block length, molarity of amine, and molarity of Au+3, and temperature on stable AuNP
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formation. Gaining insight into these areas should facilitate the synthesis of AuNPs with
predetermined sizes and binding sites based on reaction conditions.
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APPENDIX
Lower Critical Solution Behavior of P(NIPAM). Unlike traditional materials
which have increased solubility at high temperatures, the solubility of P(NIPAM)
decreases as the temperature is raised until it precipitates from solution at the point
known as the lower critical solution temperature. The solubility of the polymer can be
expressed by Equation 1, where ΔG is the change in Gibb‟s free energy, ΔH is the change
in enthalpy, T is the temperature, and ΔS is the change in entropy.

ΔG = ΔH – TΔS

(9)

For spontaneous mixing, ΔG must be negative. When P(NIPAM) is added to water at
low temperatures, the enthalpic and entropic terms are negative, resulting in spontaneous
mixing.277 The formation of hydrogen bonds between water molecules and amide
functionalities results in the negative ΔH while an increase in order resulting from the
bound water molecules participating in hydrogen bonding results in the negative ΔS.277
At higher temperatures the hydrogen bonding between water molecules and the
acrylamide groups is disrupted, leading to a positive ΔS and ΔH. At a specific
temperature, known as the LCST, the polymer will phase separate as ΔG changes from
negative to positive.
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